{"content":"<li class=\"n-box-item date-title\" data-end=\"1527134399\" data-start=\"1527048000\" data-txt=\"Monday, December 23, 2019\">Wednesday, May 23, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3359162\" data-ts=\"1527117563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGNC\" target=\"_blank\">AGNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359162-agncminus-1_8-offering-said-to-come-18_60-18_80-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AGNC -1.8% with offering said to come at $18.60-$18.80/share</a></h4><ul>   <li>AGNC Investment (NASDAQ:<a href='https://seekingalpha.com/symbol/AGNC' title='AGNC Investment Corp.'>AGNC</a>) is <font color='red'>down 1.8%</font> in postmarket trading after a <a href=\"https://seekingalpha.com/news/3359112-agnc-investment-hits-capital-raise-button-shares-1_15-percent\" target=\"_blank\">30M-share offering</a> is said to come in at $18.60-$18.80/share.</li>    <li>That's a discount of about 2-3% from the close, Bloomberg reports; AGNC wrapped up the day at $19.18.</li>    <li>Shares are <font color='green'>up 2%</font> over the past month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3359162\" data-linked=\"AGNC -1.8% with offering said to come at $18.60-$18.80/share\" data-tweet=\"$AGNC - AGNC -1.8% with offering said to come at $18.60-$18.80/share https://seekingalpha.com/news/3359162-agncminus-1_8-offering-said-to-come-18_60-18_80-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3359162-agncminus-1_8-offering-said-to-come-18_60-18_80-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359161\" data-ts=\"1527117266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EIGR\" target=\"_blank\">EIGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359161-eiger-biominus-5-40m-offering-said-to-come-12_50-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eiger Bio -5% with $40M offering said to come at $12.50/share</a></h4><ul>   <li>Eiger BioPharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EIGR' title='Eiger BioPharmaceuticals, Inc.'>EIGR</a>) is <font color='red'>5% lower</font> postmarket after a <a href=\"https://seekingalpha.com/news/3359089-eiger-bio-readies-stock-offering\" target=\"_blank\">planned stock offering</a> is said to come in at $12.50/share.</li>    <li>The company will sell $40M worth of shares at that price, Bloomberg reports. Shares closed today at $13.95, implying a 10.4% discount.</li>    <li>The company plans to use proceeds for funding its planned Phase 3 clinical trial of lonafarnib in Hepatitis Delta Virus infection, regulatory development of lonafarnib related to the treatment of Hutchison-Gilford Progeria Syndrome, and for general purposes.</li>    <li>Shares are up 40% over the past month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3359161\" data-linked=\"Eiger Bio -5% with $40M offering said to come at $12.50/share\" data-tweet=\"$EIGR - Eiger Bio -5% with $40M offering said to come at $12.50/share https://seekingalpha.com/news/3359161-eiger-biominus-5-40m-offering-said-to-come-12_50-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3359161-eiger-biominus-5-40m-offering-said-to-come-12_50-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359159\" data-ts=\"1527116538\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNS\" target=\"_blank\">MRNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359159-marinusplus-8_8-baird-bullish-on-blockbuster-drug-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marinus +8.8% with Baird bullish on &#39;blockbuster&#39; drug potential</a></h4><ul>   <li>Marinus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a>) is <font color='green'>up 8.8%</font> postmarket, following a Baird initiation at Outperform.</li>    <li>Analyst Brian Skorney sees almost triple upside with a $15 price target against today's close of $5.23, and says the mechanism of neurosuppression in Marinus' lead drug candidate, ganaxolone, has \"blockbuster potential.\"</li>    <li>He writes that the drug is similar to the brexanolone and SAGE-217 that led Sage Therapeutics to more than double over the past year \"in every way but market valuation.\" (h/t Bloomberg)</li><li>Shares are <font color='green'>up 347%</font> over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3359159\" data-linked=\"Marinus +8.8% with Baird bullish on &#39;blockbuster&#39; drug potential\" data-tweet=\"$MRNS - Marinus +8.8% with Baird bullish on &#39;blockbuster&#39; drug potential https://seekingalpha.com/news/3359159-marinusplus-8_8-baird-bullish-on-blockbuster-drug-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3359159-marinusplus-8_8-baird-bullish-on-blockbuster-drug-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359150\" data-ts=\"1527112274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359150-fox-activist-urges-murdoch-to-engage-comcast-on-asset-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fox activist urges Murdoch to engage with Comcast on asset deal</a></h4><ul>   <li>With Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) confirming today that it's <a href=\"https://seekingalpha.com/news/3358869-comcast-near-cash-offer-parts-fox\" target=\"_blank\">closing in on a cash bid</a> for Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>) media assets, Fox activist investor Chris Hohn says <a href=\"https://www.wsj.com/articles/comcast-confirms-it-is-preparing-bid-for-21st-century-fox-threatening-disney-deal-1527078344\" target=\"_blank\">he'll back Comcast's bid</a> over the $52.4B rival offer from Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>).</li>    <li>In a letter to Rupert Murdoch, Hohn revealed an unexpectedly large 7.4% stake in Fox and dismissed regulatory risk that might rise from a Comcast/Fox deal, <i>The Wall Street Journal</i> reports.</li>    <li>He wants Murdoch and company to engage with Comcast on an offer. It's widely assumed that a superior rival offer for the Fox media assets came from Comcast earlier this spring, but that Fox preferred the lower regulatory risk of selling to Disney.</li>    <li>And again, much depends competitively on the outcome of the AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>)/Time Warner (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>) trial; Comcast today wants to send a message to take its bid seriously so shareholder votes aren't rushed before the June 12 outcome of the antitrust trial.</li>    <li>In action today: <a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='red'>-1.9%</font>; <a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+1.3%</font>; <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+1.6%</font>; <a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> <font color='red'>-1.1%</font>; <a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>-0.3%; <a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a> <font color='red'>-0.5%</font>.</li>   <li>After hours: <a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='green'>+0.4%</font>; <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+1.2%</font>; <a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> <font color='red'>-0.1%</font>; <a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='red'>-0.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3359150\" data-linked=\"Fox activist urges Murdoch to engage with Comcast on asset deal\" data-tweet=\"$CMCSA $CMCSA $FOX - Fox activist urges Murdoch to engage with Comcast on asset deal https://seekingalpha.com/news/3359150-fox-activist-urges-murdoch-to-engage-comcast-on-asset-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3359150-fox-activist-urges-murdoch-to-engage-comcast-on-asset-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359146\" data-ts=\"1527111355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DEST\" target=\"_blank\">DEST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359146-after-hours-gainers-losers-05-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (05/23/2018)</a></h4><ul>     <li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/DEST' title='Destination Maternity Corporation'>DEST</a>&nbsp;<font color='green'>+25.0%</font>. <a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a>&nbsp;<font color='green'>+15.9%</font>. <a href='https://seekingalpha.com/symbol/WSM' title='Williams-Sonoma Inc.'>WSM</a> <font color='green'>+15.2%</font>. <a href='https://seekingalpha.com/symbol/SMRT' title='Stein Mart, Inc.'>SMRT</a>&nbsp;<font color='green'>+10.9%</font>. <a href='https://seekingalpha.com/symbol/LASR' title='nLIGHT, Inc.'>LASR</a> <font color='green'>+4.1%</font>.</li>     <li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='red'>-5.6%</font>. <a href='https://seekingalpha.com/symbol/EIGR' title='Eiger BioPharmaceuticals, Inc.'>EIGR</a>&nbsp;<font color='red'>-5.1%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a>&nbsp;<font color='red'>-4.8%.&nbsp;</font><a href='https://seekingalpha.com/symbol/NTAP' title='NetApp, Inc.'>NTAP</a>&nbsp;<font color='red'>-4.4%</font>. <a href='https://seekingalpha.com/symbol/PDS' title='Precision Drilling Corporation'>PDS</a>&nbsp;<font color='red'>-2.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3359146\" data-linked=\"After Hours Gainers / Losers (05/23/2018)\" data-tweet=\"$DEST $DEST $BW - After Hours Gainers / Losers (05/23/2018) https://seekingalpha.com/news/3359146-after-hours-gainers-losers-05-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3359146-after-hours-gainers-losers-05-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359128\" data-ts=\"1527108951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QUIK\" target=\"_blank\">QUIK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359128-quicklogicminus-3_1-on-public-offering-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QuickLogic -3.1% on public offering plans</a></h4><ul><li>        QuickLogic (NASDAQ:<a href='https://seekingalpha.com/symbol/QUIK' title='QuickLogic Corporation'>QUIK</a>) <a href=\"https://seekingalpha.com/pr/17172728-quicklogic-corporation-announces-proposed-public-offering-common-stock-warrants\" target=\"_blank\">announces</a> it intends to offer and sell shares of common stock and corresponding warrants in a public offering.</li><li>               Company plans to use the net proceeds from the offering for working capital and product development. &nbsp;&nbsp;</li><li>                  QuickLogic shares are&nbsp;<font color='red'>down 3.1%</font>&nbsp;aftermarket to $1.51.&nbsp;&nbsp;&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3359128\" data-linked=\"QuickLogic -3.1% on public offering plans\" data-tweet=\"$QUIK - QuickLogic -3.1% on public offering plans https://seekingalpha.com/news/3359128-quicklogicminus-3_1-on-public-offering-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3359128-quicklogicminus-3_1-on-public-offering-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359124\" data-ts=\"1527108613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BW\" target=\"_blank\">BW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359124-babcock-wilcoxplus-16-after-buyout-offer-from-steel-partners-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Babcock &amp; Wilcox +16% after buyout offer from Steel Partners Holdings</a></h4><ul>     <li>Babcock &amp;&nbsp;Wilcox (NYSE:<a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a>)&nbsp;<font color='green'>+16%</font> after-hours as Steel Partners Holdings discloses it is prepared to <a href=\"https://seekingalpha.com/filing/4037390\" target=\"_blank\">acquire all shares it does not currently own</a> for a price in the range of $3.00-3.50 in cash.</li>     <li>SPLP says its proposal is based upon the acquisition of the entire company, including BW's MEGTEC and Universal businesses.</li>     <li>SPLP says it currently owns a 17.8% stake in BW, according to SEC&nbsp;Form 13D.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3359124\" data-linked=\"Babcock &amp; Wilcox +16% after buyout offer from Steel Partners Holdings\" data-tweet=\"$BW - Babcock &amp; Wilcox +16% after buyout offer from Steel Partners Holdings https://seekingalpha.com/news/3359124-babcock-wilcoxplus-16-after-buyout-offer-from-steel-partners-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3359124-babcock-wilcoxplus-16-after-buyout-offer-from-steel-partners-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359112\" data-ts=\"1527107716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGNC\" target=\"_blank\">AGNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359112-agnc-investment-hits-capital-raise-button-shares-down-1_15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AGNC Investment hits capital raise button; shares down 1.15%</a></h4><ul><li>The company is selling 30M shares, with underwriter an greenshoe option for another 4.5M.</li><li>April 30 tangible book value was reported at $18.58 per share. Today's close was a modest premium at $19.18.</li><li><a href='https://seekingalpha.com/symbol/AGNC' title='AGNC Investment Corp.'>AGNC</a><font color='red'> -1.15%</font>&nbsp;after hours to $18.96.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17172822-b-agnc-b-investment-corp-announces-public-offering-common-stock\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3359112\" data-linked=\"AGNC Investment hits capital raise button; shares down 1.15%\" data-tweet=\"$AGNC - AGNC Investment hits capital raise button; shares down 1.15% https://seekingalpha.com/news/3359112-agnc-investment-hits-capital-raise-button-shares-down-1_15?source=tweet\" data-url=\"https://seekingalpha.com/news/3359112-agnc-investment-hits-capital-raise-button-shares-down-1_15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359104\" data-ts=\"1527107466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LB\" target=\"_blank\">LB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359104-weak-guidance-sends-l-brands-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak guidance sends L Brands lower</a></h4><ul><li>L Brands (NYSE:<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a>) falls sharply after setting profit guidance below expectations.</li><li>The retailer expects Q2 EPS of $0.30 to $0.35 vs. $0.40 consensus and FY19 EPS of&nbsp;$2.70 to $3.00 vs $3.01 consensus.</li><li>LB&nbsp;<font color='red'>-6.52%</font>&nbsp;AH to $31.83.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3359086-l-brands-misses-0_01-beats-revenue\" target=\"_blank\">L Brands misses by $0.01, beats on revenue</a> (May 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3359104\" data-linked=\"Weak guidance sends L Brands lower\" data-tweet=\"$LB - Weak guidance sends L Brands lower https://seekingalpha.com/news/3359104-weak-guidance-sends-l-brands-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3359104-weak-guidance-sends-l-brands-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>59&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359098\" data-ts=\"1527107085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNPS\" target=\"_blank\">SNPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359098-synopsysplus-1_8-on-q2-beat-upside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synopsys +1.8% on Q2 beat, upside guidance</a></h4><ul><li>        Synopsys (NASDAQ:<a href='https://seekingalpha.com/symbol/SNPS' title='Synopsys, Inc.'>SNPS</a>)&nbsp;<font color='green'>gains 1.8%</font>&nbsp;aftermarket on Q2 results that beat revenue estimates with a 14% Y/Y growth and met on EPS. Upside Q3 guidance has revenue from $760M to $785M (consensus: $700.57M) and EPS form $0.89 to $0.93 (consensus: $0.78).&nbsp;</li><li>        Upside FY18 guidance has revenue from $3.07B to $3.10B (consensus: $2.94B) and EPS from $3.76 to $3.83 (consensus: $3.72).</li><li>               Earnings call is scheduled for 5 PM Eastern with a webcast available <a href=\"https://www.synopsys.com/\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17172763-synopsys-posts-financial-results-second-quarter-fiscal-year-2018\" target=\"_blank\">Press release</a>. &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3359076-synopsys-eps-line-beats-revenue\" target=\"_blank\">Synopsys EPS in-line, beats on revenue</a> (May 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3359098\" data-linked=\"Synopsys +1.8% on Q2 beat, upside guidance\" data-tweet=\"$SNPS - Synopsys +1.8% on Q2 beat, upside guidance https://seekingalpha.com/news/3359098-synopsysplus-1_8-on-q2-beat-upside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3359098-synopsysplus-1_8-on-q2-beat-upside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359089\" data-ts=\"1527106742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EIGR\" target=\"_blank\">EIGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359089-eiger-bio-readies-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eiger Bio readies stock offering</a></h4><ul><li>Eiger BioPharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EIGR' title='Eiger BioPharmaceuticals, Inc.'>EIGR</a>) <a href=\"https://seekingalpha.com/pr/17172802-eiger-biopharmaceuticals-announces-proposed-public-offering-common-stock\" target=\"_blank\">initiates </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3359089\" data-linked=\"Eiger Bio readies stock offering\" data-tweet=\"$EIGR - Eiger Bio readies stock offering https://seekingalpha.com/news/3359089-eiger-bio-readies-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3359089-eiger-bio-readies-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359087\" data-ts=\"1527106667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WSM\" target=\"_blank\">WSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359087-williams-sonoma-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Williams-Sonoma beats by $0.09, beats on revenue</a></h4><ul><li>Williams-Sonoma (NYSE:<a href='https://seekingalpha.com/symbol/WSM' title='Williams-Sonoma Inc.'>WSM</a>): Q1 EPS of $0.67 <font color='green'>beats by $0.09</font>.</li><li>Revenue of $1.2B (+8.1% Y/Y) <font color='green'>beats by $40M</font>.</li><li>Shares <font color='green'>+6.5%</font>.</li><li><a href='https://seekingalpha.com/pr/17172793-williams-sonoma-inc-reports-strong-first-quarter-2018-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3359087\" data-linked=\"Williams-Sonoma beats by $0.09, beats on revenue\" data-tweet=\"$WSM - Williams-Sonoma beats by $0.09, beats on revenue https://seekingalpha.com/news/3359087-williams-sonoma-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3359087-williams-sonoma-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359082\" data-ts=\"1527106593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTAP\" target=\"_blank\">NTAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359082-netappminus-3_4-despite-q4-beats-in-line-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetApp -3.4% despite Q4 beats, in-line guidance</a></h4><ul><li>        NetApp (NASDAQ:<a href='https://seekingalpha.com/symbol/NTAP' title='NetApp, Inc.'>NTAP</a>) drops 3.4% on Q4 results that beat EPS and revenue estimates with an 11% Y/Y revenue growth. In-line Q1 guidance has revenue from $1.365B to $1.465B (consensus: $1.42B) and EPS from $0.76 to $0.82 (consensus: $0.78). FY19 guidance has mid-single digit revenue growth.</li><li>               Key metrics: Cash from operations, $494M (+$129M Y/Y); cash and equivalents, $5.4B; capital allocation, $397M; operating expenses, $735M.&nbsp;</li><li>               Earnings call is scheduled for 5 PM Eastern with a webcast available <a href=\"http://investors.netapp.com/\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17172727-netapp-reports-fourth-quarter-fiscal-year-2018-results\" target=\"_blank\">Press release</a>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3359066-netapp-beats-0_04-beats-revenue\" target=\"_blank\">NetApp beats by $0.04, beats on revenue</a> (May 23)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3359069-netapp-declares-0_40-dividend\" target=\"_blank\">NetApp declares $0.40 dividend</a> (May 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3359082\" data-linked=\"NetApp -3.4% despite Q4 beats, in-line guidance\" data-tweet=\"$NTAP - NetApp -3.4% despite Q4 beats, in-line guidance https://seekingalpha.com/news/3359082-netappminus-3_4-despite-q4-beats-in-line-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3359082-netappminus-3_4-despite-q4-beats-in-line-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359078\" data-ts=\"1527106181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMRT\" target=\"_blank\">SMRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359078-stein-mart-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stein Mart reports Q1 results</a></h4><ul><li>Stein Mart (NASDAQ:<a href='https://seekingalpha.com/symbol/SMRT' title='Stein Mart, Inc.'>SMRT</a>): Q1 EPS of $0.16</li><li>Revenue of $326.69M (-3.2% Y/Y)</li><li>Shares <font color='green'>+12.19%</font>.</li><li><a href='https://seekingalpha.com/pr/17172739-stein-mart-inc-reports-first-quarter-fiscal-2018-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3359078\" data-linked=\"Stein Mart reports Q1 results\" data-tweet=\"$SMRT - Stein Mart reports Q1 results https://seekingalpha.com/news/3359078-stein-mart-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3359078-stein-mart-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359067\" data-ts=\"1527105785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPE\" target=\"_blank\">HPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359067-hpe-closesminus-10_6-on-challenging-second-half-comment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HPE closes -10.6% on &quot;challenging second half&quot; comment</a></h4><ul><li>        Hewlett Packard Enterprise (NYSE:<a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise'>HPE</a>) shares closed today&nbsp;<font color='red'>down 10.6%</font>&nbsp;after CEO Antonio Neri warned of a &ldquo;challenging second half&rdquo; of the year.</li><li>               Neri: &ldquo;We expect the growth rate to moderate. While we see a more challenging second half, we have got great momentum, and I&rsquo;m confident that we can deliver on our annual fiscal year 2018 outlook.&rdquo;&nbsp;</li><li>               Earnings call <a href=\"https://seekingalpha.com/article/4176377-hewlett-packard-enterprise-hpe-ceo-antonio-neri-q2-2018-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript</a>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358721-hewlett-packard-enterprise-reports-q2-beats-10-percent-rev-growth-upside-fy-guide\" target=\"_blank\">Hewlett Packard Enterprise reports Q2 beats, 10% rev. growth, upside FY guide</a> (May 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3359067\" data-linked=\"HPE closes -10.6% on &quot;challenging second half&quot; comment\" data-tweet=\"$HPE - HPE closes -10.6% on &quot;challenging second half&quot; comment https://seekingalpha.com/news/3359067-hpe-closesminus-10_6-on-challenging-second-half-comment?source=tweet\" data-url=\"https://seekingalpha.com/news/3359067-hpe-closesminus-10_6-on-challenging-second-half-comment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359065\" data-ts=\"1527105735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGC\" target=\"_blank\">BGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359065-general-cableplus-2_2-doj-says-not-investigating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">General Cable +2.2%; DOJ says not investigating</a></h4><ul><li>Bloomberg is reporting the DOJ as saying General Cable (<a href='https://seekingalpha.com/symbol/BGC' title='General Cable Corporation'>BGC</a> <font color='green'>+2.2%</font>) is not under investigation.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358834-general-cable-responds-alleged-investigation\" target=\"_blank\">General Cable responds to alleged investigation</a> (May 23)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358682-general-cable-slumps-4-percent-report-government-probe\" target=\"_blank\">General Cable slumps 4% on report of government probe</a> (May 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3359065\" data-linked=\"General Cable +2.2%; DOJ says not investigating\" data-tweet=\"$BGC - General Cable +2.2%; DOJ says not investigating https://seekingalpha.com/news/3359065-general-cableplus-2_2-doj-says-not-investigating?source=tweet\" data-url=\"https://seekingalpha.com/news/3359065-general-cableplus-2_2-doj-says-not-investigating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359062\" data-ts=\"1527105547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEE\" target=\"_blank\">AEE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359062-amerenplus-2-goldman-upgrades-from-sell-on-bright-union-electric-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ameren +2% as Goldman upgrades from Sell on bright Union Electric outlook</a></h4><ul>     <li>Ameren (<a href='https://seekingalpha.com/symbol/AEE' title='Ameren Corporation'>AEE</a> <font color='green'>+2.1%</font>) is higher after Goldman Sachs <a href=\"https://thefly.com/thestreet/realmoney/index.php/AEEid2735194/AEE-Ameren-upgraded-to-Neutral-with--price-target-at-Goldman-Sachs\" target=\"_blank\">upgrades</a> shares to Neutral from Sell with a $61 price target, raised from $55, at Goldman Sachs, which raises its estimates above consensus through 2021, particularly in 2020, because of an improved outlook at Union Electric.</li>     <li>Goldman foresees AEE's earnings rising 10% Y/Y in 2020 as 700 MW of wind generation gets added to Union Electric's rate base, which the firm says will mean an improved valuation relative to peers.</li><li><a href=\"https://seekingalpha.com/news/3358420-ameren-unveils-plans-missouris-largest-wind-farm\" target=\"_blank\">Earlier this week</a>, AEE unveiled plans to build a 400 MW wind farm in Missouri, the state largest such project.</li></ul><div class=\"tiny-share-widget\" data-id=\"3359062\" data-linked=\"Ameren +2% as Goldman upgrades from Sell on bright Union Electric outlook\" data-tweet=\"$AEE - Ameren +2% as Goldman upgrades from Sell on bright Union Electric outlook https://seekingalpha.com/news/3359062-amerenplus-2-goldman-upgrades-from-sell-on-bright-union-electric-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3359062-amerenplus-2-goldman-upgrades-from-sell-on-bright-union-electric-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359061\" data-ts=\"1527104874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359061-geminus-7_5-flannery-makes-no-promises-2019-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE -7.5% as Flannery makes no promises about 2019 dividend</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-7.5%</font>) shares extend already sizable losses that were the result of company <a href=\"https://seekingalpha.com/news/3359007-ge-minus-5-percent-flannery-sees-profit-growth-year-power-unit\" target=\"_blank\">guidance that warned</a> of continued weakness in its power business and reaffirmed targets for 2018 earnings and free cash flow.</li>     <li>But the large loss turned into the stock's biggest daily percentage decline since John Flannery became CEO last August after he <a href=\"https://www.reuters.com/article/us-ge-ceo/ge-cannot-guarantee-dividend-still-fixing-some-units-ceo-says-idUSKCN1IO2GE\" target=\"_blank\">failed to guarantee GE's 2019 dividend</a>, saying instead that \"we have to see how this plays out.\"</li>     <li>Following up on <a href=\"https://seekingalpha.com/news/3358346-ge-sheds-part-days-gain-gasparino-tweets-dividend-cut\" target=\"_blank\">recent speculation</a> about the dividend, Barclays analyst Julian Mitchell <a href=\"https://www.barrons.com/articles/general-electric-is-it-something-we-said-1527094702\" target=\"_blank\">asked Flannery</a> if he could \"stand behind the $0.48 dividend in 2019.\"</li>     <li>&ldquo;It&rsquo;s ultimately a function of the free cash flow of the company and that&rsquo;s ultimately a function of operating performance and things that we do with the portfolio,&rdquo; Flannery said at the annual Electrical Products Group conference in Florida.</li>     <li>&ldquo;The primary takeaway is the dividend will be cut as assets are sold,&rdquo; says Vertical Research analyst Jeff Sprague. &ldquo;Proceeds from sales have to go to debt reduction. Cash flow from assets sold is obviously gone, making [the] dividend unsustainable.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3359061\" data-linked=\"GE -7.5% as Flannery makes no promises about 2019 dividend\" data-tweet=\"$GE - GE -7.5% as Flannery makes no promises about 2019 dividend https://seekingalpha.com/news/3359061-geminus-7_5-flannery-makes-no-promises-2019-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3359061-geminus-7_5-flannery-makes-no-promises-2019-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>110&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359060\" data-ts=\"1527104811\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASY\" target=\"_blank\">CASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359060-jana-denies-caseys-general-stores-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jana denies Casey&#39;s General Stores report</a></h4><ul><li>Shares of Casey's General Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/CASY' title='Casey&#39;s General Stores, Inc.'>CASY</a>) are now only&nbsp;<font color='green'>up 1.42%</font>&nbsp;after Jana Partners tells <a href=\"https://twitter.com/CNBCnow/status/999374652114898944\" target=\"_blank\">CNBC</a> that it doesn't own a single share of the retailer.</li><li>The original report sent shares of Casey's up over 7% before the bubble was burst.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3359059-jana-partners-reported-stake-caseys-general-stores\" target=\"_blank\">Jana Partners reported to have stake in Casey's General Stores</a> (May 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3359060\" data-linked=\"Jana denies Casey&#39;s General Stores report\" data-tweet=\"$CASY - Jana denies Casey&#39;s General Stores report https://seekingalpha.com/news/3359060-jana-denies-caseys-general-stores-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3359060-jana-denies-caseys-general-stores-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359052\" data-ts=\"1527103138\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGR\" target=\"_blank\">AGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359052-avangrid-backed-project-wins-800-mw-wind-farm-offshore-massachusetts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avangrid-backed project wins 800 MW wind farm offshore Massachusetts</a></h4><ul>     <li>Avangrid (<a href='https://seekingalpha.com/symbol/AGR' title='Avangrid, Inc.'>AGR</a> <font color=\"green\">+2.4%</font>) jumps after Massachusetts utilities officials select Vineyard Wind to <a href=\"http://www.wbur.org/bostonomix/2018/05/23/vineyard-wind-massachusetts-offshore-farm\" target=\"_blank\">build an 800 MW wind farm</a> off the coast of Martha's Vineyard, beating two competitors.</li><li>The selection is  contingent upon successful negotiations of a contract with Vineyard  Wind, a 50-50 joint venture with Avangrid Renewables and Copenhagen Infrastructure Partners.</li><li>Vineyard Wind beat out  competing proposals from Deepwater Wind and Bay State Wind, which was a  partnership between Danish firm Orsted (<a href='https://seekingalpha.com/symbol/DNNGY' title='Ørsted A/S'>OTCPK:DNNGY</a>) and Eversource (<a href='https://seekingalpha.com/symbol/ES' title='Eversource Energy'>ES</a> <font color=\"red\">-2.3%</font>); Deepwater Wind is chosen to <a href=\"http://www.thenewportbuzz.com/rhode-island-selects-deepwater-wind-to-build-a-new-400-megawatt-offshore-wind-farm/15755\" target=\"_blank\">develop a separate 400 MW offshore wind farm</a> for Rhode Island.</li><li>Construction of Vineyard Wind's project is expected to begin in 2019 with the  turbines becoming operational by 2021.</li></ul><div class=\"tiny-share-widget\" data-id=\"3359052\" data-linked=\"Avangrid-backed project wins 800 MW wind farm offshore Massachusetts\" data-tweet=\"$AGR $DNNGY $ES - Avangrid-backed project wins 800 MW wind farm offshore Massachusetts https://seekingalpha.com/news/3359052-avangrid-backed-project-wins-800-mw-wind-farm-offshore-massachusetts?source=tweet\" data-url=\"https://seekingalpha.com/news/3359052-avangrid-backed-project-wins-800-mw-wind-farm-offshore-massachusetts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359048\" data-ts=\"1527102641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359048-oragenics-nabs-u-s-patent-covering-lantibiotics-shares-up-33\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oragenics nabs U.S. patent covering Lantibiotics; shares up 33%</a></h4><ul><li>Nano cap Oragenics (<a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+32.5%</font>) jumps on a 5x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/17172616-oragenics-inc-texas-and-m-university-system-granted-u-s-patent-lantibiotic-mu1140\" target=\"_blank\">announcement </a>that the USPTO has awarded it and The Texas A&amp;M University System U.S. Patent No. 9,964,488 covering the composition of Lantibiotics and methods of use.</li></ul><div class=\"tiny-share-widget\" data-id=\"3359048\" data-linked=\"Oragenics nabs U.S. patent covering Lantibiotics; shares up 33%\" data-tweet=\"$OGEN - Oragenics nabs U.S. patent covering Lantibiotics; shares up 33% https://seekingalpha.com/news/3359048-oragenics-nabs-u-s-patent-covering-lantibiotics-shares-up-33?source=tweet\" data-url=\"https://seekingalpha.com/news/3359048-oragenics-nabs-u-s-patent-covering-lantibiotics-shares-up-33\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359045\" data-ts=\"1527102032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDR\" target=\"_blank\">BDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359045-technology-top-5-gainers-losers-of-3_00-pm-05-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3.00 PM (05/23/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/BDR' title='Blonder Tongue Laboratories, Inc'>BDR</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/KONE' title='Kingtone Wirelessinfo Solution Holding Ltd'>KONE</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/JCS' title='Communications Systems, Inc.'>JCS</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/BBOX' title='Black Box Corporation'>BBOX</a> <font color='green'>+11%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/IGLD' title='Internet Gold Golden Lines Ltd.'>IGLD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise'>HPE</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/FTRPR' title='Frontier Communications Corporation Mand Conv Pfd Shs Series A'>FTRPR</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3359045\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3.00 PM (05/23/2018)\" data-tweet=\"$BDR $BDR $USAT - Technology - Top 5 Gainers / Losers as of 3.00 PM (05/23/2018) https://seekingalpha.com/news/3359045-technology-top-5-gainers-losers-of-3_00-pm-05-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3359045-technology-top-5-gainers-losers-of-3_00-pm-05-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359043\" data-ts=\"1527101878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEL\" target=\"_blank\">AEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359043-american-equity-investment-confirms-in-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Equity Investment confirms it&#39;s in talks</a></h4><ul><li>American Equity Investment Life (<a href='https://seekingalpha.com/symbol/AEL' title='American Equity Investment Life Holding Company'>AEL</a> <font color='green'>+8.4%</font>) confirms that it's in preliminary talks regarding a potential transaction.</li><li>The company said it can't assure that the talks will continue or that any definitive agreement will be reached.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17171899-american-equity-addresses-market-rumors\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3358699-american-equity-nearly-8-percent-sale-chatter\" target=\"_blank\">American Equity up nearly 8% on sale chatter</a> (May 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3359043\" data-linked=\"American Equity Investment confirms it&#39;s in talks\" data-tweet=\"$AEL - American Equity Investment confirms it&#39;s in talks https://seekingalpha.com/news/3359043-american-equity-investment-confirms-in-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3359043-american-equity-investment-confirms-in-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359040\" data-ts=\"1527100749\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359040-apple-watch-shipments-up-wearables-grow-35-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple Watch shipments up as wearables grow 35% in Q1</a></h4><ul><li>Shipments of wearables like the Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='green'>+0.1%</font>) Watch grew 35% in Q1, according to <a href=\"https://appleinsider.com/articles/18/05/23/apple-watch-leads-wearable-device-market-with-estimated-38m-unit-shipments-in-first-quarter\" target=\"_blank\">Canalys data</a>.</li><li>Apple shipped 3.8M Watches in the period, narrowly beating out Xiaomi&rsquo;s (<a href='https://seekingalpha.com/symbol/XI' title='Xiaomi'>XI</a>) 3.7M.</li><li>Apple and Xiaomi each held 18% of the wearable band shipments in the quarter.</li><li>The rest of the top 5 by market share: Fitbit (<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a> <font color='red'>-0.8%</font>), 11%; Garmin (<a href='https://seekingalpha.com/symbol/GRMN' title='Garmin Ltd.'>GRMN</a> <font color='red'>-0.4%</font>), 7%; Huawei, 6%.</li><li>Smartwatches accounted for 43% of the wearable band market with the rest consisting of basic bands.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3343324-tsmc-will-reportedly-produce-two-microled-panels-apple-watch-ar-device\" target=\"_blank\">TSMC will reportedly produce two MicroLED panels for Apple Watch, AR device</a> (April 3)</li><li>Update: Post updated to correct headline, intro sentence.</li></ul><div class=\"tiny-share-widget\" data-id=\"3359040\" data-linked=\"Apple Watch shipments up as wearables grow 35% in Q1\" data-tweet=\"$AAPL $AAPL $XI - Apple Watch shipments up as wearables grow 35% in Q1 https://seekingalpha.com/news/3359040-apple-watch-shipments-up-wearables-grow-35-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3359040-apple-watch-shipments-up-wearables-grow-35-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359038\" data-ts=\"1527100060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARLP\" target=\"_blank\">ARLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359038-alliance-resource-upgraded-to-buy-mkm-on-compelling-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliance Resource upgraded to Buy at MKM on compelling valuation</a></h4><ul>     <li>Alliance Resource Partners (<a href='https://seekingalpha.com/symbol/ARLP' title='Alliance Resource Partners, L.P.'>ARLP</a> <font color='green'>+1.6%</font>) is higher after MKM&nbsp;Partners <a href=\"https://thefly.com/thestreet/realmoney/index.php/ARLPid2735568/ARLP-Alliance-Resource-Partners-upgraded-to-Buy-at-MKM-Partners-on-valuation\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $22 price target, up from $21, saying units trade at 4.4x EV/EBITDA on 2018 estimates and 5x on 2019 estimates, near the bottom of their peer group</li>     <li>MKM cites a \"good quarter with a guidance increase\" as export expectations in FY 2018 rose to ~20% total sales for the year, adding that production of thermal coal in the Illinois Basin and coking coal out of Appalachia were strong.</li>     <li>The firm also notes the solid quarter came despite delayed shipments of 1.4M tons of coal due to weather-related transportation disruptions on the river system.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3359038\" data-linked=\"Alliance Resource upgraded to Buy at MKM on compelling valuation\" data-tweet=\"$ARLP - Alliance Resource upgraded to Buy at MKM on compelling valuation https://seekingalpha.com/news/3359038-alliance-resource-upgraded-to-buy-mkm-on-compelling-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3359038-alliance-resource-upgraded-to-buy-mkm-on-compelling-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359035\" data-ts=\"1527099371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLEX\" target=\"_blank\">LLEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359035-lilis-energyplus-9-on-crude-oil-gathering-agreement-salt-creek-midstream\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lilis Energy +9% on crude oil gathering agreement with Salt Creek Midstream</a></h4><ul>     <li>Lilis Energy (<a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a> <font color='green'>+8.8%</font>) surges after announcing a <a href=\"http://investors.lilisenergy.com/phoenix.zhtml?c=225413&amp;p=irol-newsArticle&amp;ID=2350381\" target=\"_blank\">crude oil gathering agreement</a> with Salt Creek Midstream, which is developing a new regional pipeline system in Texas and New Mexico to a terminal in Winkler County, Tex., linking to long-haul downstream pipelines.</li>     <li>LLEX says it will provide its acreage dedication with no volume or capex commitments and Salt Creek will provide all capital for the oil gathering system, with construction expected to begin immediately and service set to start next year.</li>     <li>LLEX and Salt Creek also reach an option agreement paying Lilis for selected natural gas midstream services.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3359035\" data-linked=\"Lilis Energy +9% on crude oil gathering agreement with Salt Creek Midstream\" data-tweet=\"$LLEX - Lilis Energy +9% on crude oil gathering agreement with Salt Creek Midstream https://seekingalpha.com/news/3359035-lilis-energyplus-9-on-crude-oil-gathering-agreement-salt-creek-midstream?source=tweet\" data-url=\"https://seekingalpha.com/news/3359035-lilis-energyplus-9-on-crude-oil-gathering-agreement-salt-creek-midstream\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359031\" data-ts=\"1527098508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMLP-OLD\" target=\"_blank\">WMLP-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359031-energy-materials-top-5-gainers-losers-of-2-00-pm-05-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (05/23/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a> <font color='green'>+177%</font>. <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/BPT' title='BP Prudhoe Bay Royalty Trust'>BPT</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GSM' title='Ferroglobe PLC'>GSM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/VEDL' title='Vedanta Ltd'>VEDL</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/TGB' title='Taseko Mines Limited'>TGB</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3359031\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (05/23/2018)\" data-tweet=\"$WMLP-OLD $WMLP-OLD $SNES - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (05/23/2018) https://seekingalpha.com/news/3359031-energy-materials-top-5-gainers-losers-of-2-00-pm-05-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3359031-energy-materials-top-5-gainers-losers-of-2-00-pm-05-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359030\" data-ts=\"1527098104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOW\" target=\"_blank\">LOW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359030-ackman-said-to-take-stake-in-lowes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ackman said to take stake in Lowe&#39;s</a></h4><ul> <li>Pershing Square Capital Management teamed up with another activist investor to take a <a href=\"https://www.wsj.com/articles/ackman-takes-roughly-1-billion-stake-in-lowes-1527092151\" target=\"_blank\">+$1B</a> stake in Lowe's (<a href='https://seekingalpha.com/symbol/LOW' title='Lowe&#39;s Companies, Inc.'>LOW</a> <font color='green'>+9.9%</font>), sources tell <em>The Wall Street Journal</em>.</li> <li>Pershing founder Bill Ackman reportedly supports the decision of the company to bring in former J.C. Penney chief Marvin Ellison as CEO. Of course, Ackman lost a fortune with an ill-timed bet on former J.C. Penney CEO Ron Johnson.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3359030\" data-linked=\"Ackman said to take stake in Lowe&#39;s\" data-tweet=\"$LOW - Ackman said to take stake in Lowe&#39;s https://seekingalpha.com/news/3359030-ackman-said-to-take-stake-in-lowes?source=tweet\" data-url=\"https://seekingalpha.com/news/3359030-ackman-said-to-take-stake-in-lowes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359027\" data-ts=\"1527096367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRIS\" target=\"_blank\">CRIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359027-curis-continues-selloff-ahead-of-reverse-split-down-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Curis continues selloff ahead of reverse split, down 14%</a></h4><ul><li>Curis (<a href='https://seekingalpha.com/symbol/CRIS' title='Curis, Inc.'>CRIS</a> <font color='red'>-13.7%</font>) is down on 70% higher volume. Shares have sold off almost 25% since last week. Yesterday after the close, it <a href=\"https://seekingalpha.com/pr/17171407-curis-announces-1minus-5-reverse-stock-split\" target=\"_blank\">announced </a>a 1:5 reverse stock split to take effect on Tuesday, May 29.</li></ul><div class=\"tiny-share-widget\" data-id=\"3359027\" data-linked=\"Curis continues selloff ahead of reverse split, down 14%\" data-tweet=\"$CRIS - Curis continues selloff ahead of reverse split, down 14% https://seekingalpha.com/news/3359027-curis-continues-selloff-ahead-of-reverse-split-down-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3359027-curis-continues-selloff-ahead-of-reverse-split-down-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359023\" data-ts=\"1527095417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359023-espn-confirms-and-details-1_5b-ufc-rights-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ESPN confirms and details $1.5B UFC rights deal</a></h4><ul>   <li>ESPN (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='red'>-1%</font>) has <a href=\"http://www.espn.com/mma/story/_/id/23581729/espn-ufc-reach-five-year-television-rights-deal\" target=\"_blank\">confirmed its five-year deal</a> with the UFC, a pact that elbows out previous exclusive rights partner Fox Sports (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+1.8%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+2.1%</font>) to make ESPN the UFC's new home.</li>    <li>The package costs $1.5B over five years, a substantial step up from Fox's payments.</li>    <li>In combination with an earlier deal, the package will encompass 30 Fight Night events (each with 12 bouts) each year, including 10 main cards on ESPN TV networks, with the other 20 streaming on ESPN Plus.</li>    <li>ESPN networks will also show preliminary bouts before 12 pay-per-view events in 2019.</li>    <li><a href='https://seekingalpha.com/symbol/WWE' title='World Wrestling Entertainment, Inc.'>WWE</a> has legged up recently as the new deals are helping set a high price for its negotiations with Fox, jumping on <i>SmackDown</i> rights after NBCUniversal passed on its first rights.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3359023\" data-linked=\"ESPN confirms and details $1.5B UFC rights deal\" data-tweet=\"$FOX $FOX $FOXA - ESPN confirms and details $1.5B UFC rights deal https://seekingalpha.com/news/3359023-espn-confirms-and-details-1_5b-ufc-rights-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3359023-espn-confirms-and-details-1_5b-ufc-rights-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359022\" data-ts=\"1527095278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBR\" target=\"_blank\">EBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359022-eletrobrasminus-10-privatization-hopes-fade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eletrobras -10% as privatization hopes fade</a></h4><ul>     <li>Eletrobras (<a href='https://seekingalpha.com/symbol/EBR' title='Centrais Eletricas Brasileiras S.A. - Eletrobras'>EBR</a> <font color='red'>-10.1%</font>) plunges ~10% after the head of Brazil's lower house of Congress said it <a href=\"https://www.reuters.com/article/eletrobras-privatization/update-1-eletrobras-shares-sink-as-privatization-hopes-fade-idUSL2N1SU0QL\" target=\"_blank\">would not vote</a> on a presidential decree outlining rules for the sale of state-controlled power companies, instead asking Pres. Temer to send a draft bill.</li>     <li>The decision likely ends the planned privatization of the state-run power company and some of its subsidiaries for this year.</li>     <li>With Brazil's general election scheduled for October, the Congress likely will not have enough time to evaluate and vote on a new draft bill.</li>     <li>Shares of Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='red'>-3.1%</font>) also are sharply lower.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWZ' title='iShares MSCI Brazil Capped ETF'>EWZ</a>, <a href='https://seekingalpha.com/symbol/BRZU' title='Direxion Daily Brazil Bull 3x Shares ETF'>BRZU</a>, <a href='https://seekingalpha.com/symbol/BZQ' title='ProShares UltraShort MSCI Brazil Capped ETF'>BZQ</a>, <a href='https://seekingalpha.com/symbol/UBR' title='ProShares Ultra MSCI Brazil Capped ETF'>UBR</a>, <a href='https://seekingalpha.com/symbol/DBBR' title='Deutsche X-trackers MSCI Brazil Hedged Equity ETF'>DBBR</a>, <a href='https://seekingalpha.com/symbol/FBZ' title='First Trust Brazil AlphaDEX ETF'>FBZ</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3359022\" data-linked=\"Eletrobras -10% as privatization hopes fade\" data-tweet=\"$EBR $EBR $PBR - Eletrobras -10% as privatization hopes fade https://seekingalpha.com/news/3359022-eletrobrasminus-10-privatization-hopes-fade?source=tweet\" data-url=\"https://seekingalpha.com/news/3359022-eletrobrasminus-10-privatization-hopes-fade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359019\" data-ts=\"1527094846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YRIV\" target=\"_blank\">YRIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359019-financials-top-gainers-losers-of-1-00-pm-05-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (05/23/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/AEL' title='American Equity Investment Life Holding Company'>AEL</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance'>XRF</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MFIN' title='Medallion Financial'>MFIN</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/IBTX' title='Independent Bank Group'>IBTX</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3359019\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (05/23/2018)\" data-tweet=\"$YRIV $YRIV $AEL - Financials - Top Gainers / Losers as of 1:00 PM (05/23/2018) https://seekingalpha.com/news/3359019-financials-top-gainers-losers-of-1-00-pm-05-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3359019-financials-top-gainers-losers-of-1-00-pm-05-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359010\" data-ts=\"1527093405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMLP-OLD\" target=\"_blank\">WMLP-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359010-midday-gainers-losers-05-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (05/23/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a> <font color='green'>+172%</font>. <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+53%</font>. <a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/BDR' title='Blonder Tongue Laboratories, Inc'>BDR</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/TIF' title='Tiffany & Co.'>TIF</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/RL' title='Ralph Lauren Corporation'>RL</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/AMDA' title='Amedica Corporation'>AMDA</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a> <font color='green'>+13%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/FWP' title='Forward Pharma'>FWP</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/RRGB' title='Red Robin Gourmet Burgers, Inc.'>RRGB</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/CDTI' title='Clean Diesel Technologies, Inc.'>OTC:CDTI</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/CMTA' title='Clementia Pharmaceuticals'>CMTA</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx'>ARDX</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/PFNX' title='Pfenex'>PFNX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TCS' title='The Container Store Group, Inc.'>TCS</a> <font color='red'>-11%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3359010\" data-linked=\"Midday Gainers / Losers (05/23/2018)\" data-tweet=\"$WMLP-OLD $WMLP-OLD $AVGR - Midday Gainers / Losers (05/23/2018) https://seekingalpha.com/news/3359010-midday-gainers-losers-05-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3359010-midday-gainers-losers-05-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359009\" data-ts=\"1527093356\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DISH\" target=\"_blank\">DISH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359009-dish-gives-official-launch-to-airtv-service\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dish gives official launch to AirTV service</a></h4><ul>   <li>Dish DBS (<a href=\"http://seekingalpha.com/symbol/DISH\" target=\"_blank\">DISH</a> <font color='red'>-2.5%</font>) has given an <a href=\"https://www.multichannel.com/news/dish-dbs-officially-launches-airtv\" target=\"_blank\">official launch to AirTV</a>, its over-the-top service to provide home and remote access to broadcast channels.</li>    <li>That allows customers to use the Sling TV app or AirTV app to see local broadcast channels on various devices at no additional charge; custoemrs only buy hardware that retails for just under $120.</li>    <li>It works with an existing Sling TV subscription but doesn't require one.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3359009\" data-linked=\"Dish gives official launch to AirTV service\" data-tweet=\"$DISH - Dish gives official launch to AirTV service https://seekingalpha.com/news/3359009-dish-gives-official-launch-to-airtv-service?source=tweet\" data-url=\"https://seekingalpha.com/news/3359009-dish-gives-official-launch-to-airtv-service\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359007\" data-ts=\"1527093318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359007-geminus-5-flannery-sees-no-profit-growth-this-year-power-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE -5% as Flannery sees no profit growth this year at power unit</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-5.4%</font>) gives up more than a week's worth of gains after CEO John Flannery says he expects <a href=\"https://www.reuters.com/article/us-ge-ceo/ge-ceo-sees-no-profit-growth-at-power-unit-this-year-idUSKCN1IO2GE\" target=\"_blank\">no profit growth in its power business this year</a> and is planning for the market for heavy duty gas power turbines to remain weak through 2020, according to <a href=\"https://www.ge.com/investor-relations/sites/default/files/ge_webcast_presentation_052318_0.pdf\" target=\"_blank\">presentation slides</a> for the 2018 Electrical Products Group Conference.</li><li>GE also reaffirms its targets for 2018 EPS of $1.00-$1.07 and free cash flow generation of $6B-$7B, and expects profit at its Baker Hughes (<a href='https://seekingalpha.com/symbol/BHGE' title='Baker Hughes, a GE company'>BHGE</a> <font color='red'>-0.7%</font>) oil and gas unit to rise by 50% or more this year while forecasting profit rising 15% at the aviation business and 5% in healthcare.</li></ul><div class=\"tiny-share-widget\" data-id=\"3359007\" data-linked=\"GE -5% as Flannery sees no profit growth this year at power unit\" data-tweet=\"$GE $GE $BKR - GE -5% as Flannery sees no profit growth this year at power unit https://seekingalpha.com/news/3359007-geminus-5-flannery-sees-no-profit-growth-this-year-power-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3359007-geminus-5-flannery-sees-no-profit-growth-this-year-power-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>166&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359006\" data-ts=\"1527092946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359006-otr-global-downgrades-workday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OTR Global downgrades Workday</a></h4><ul><li>        OTR Global <a href=\"https://www.streetinsider.com/Downgrades/OTR+Global+Downgrades+Workday+%28WDAY%29+to+Mixed/14228671.html\" target=\"_blank\">downgrades</a> Workday (NYSE:<a href='https://seekingalpha.com/symbol/WDAY' title='Workday'>WDAY</a>) from Positive to Mixed.</li><li>                  Workday shares are&nbsp;<font color='red'>down 1.8%</font>&nbsp;to $128.   &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3359006\" data-linked=\"OTR Global downgrades Workday\" data-tweet=\"$WDAY - OTR Global downgrades Workday https://seekingalpha.com/news/3359006-otr-global-downgrades-workday?source=tweet\" data-url=\"https://seekingalpha.com/news/3359006-otr-global-downgrades-workday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3359000\" data-ts=\"1527091721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRX\" target=\"_blank\">ACRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3359000-leerink-led-investors-acquire-three-arch-stake-in-acelrx-shares-up-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leerink-led investors acquire Three Arch stake in AcelRx; shares up 7%</a></h4><ul><li>AcelRx Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='green'>+6.9%</font>) is up on average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17171687-three-archs-shares-acelrx-common-stock-acquired-private-transaction-led-leerink-revelation\" target=\"_blank\">announcement </a>that the ~9.4M shares owned by funds managed by Three Arch Partners have been acquired by investors led by Leerink Revelation Partners and Industry Ventures.</li><li>The Three Arch funds are in the process of dissolution.</li><li>CEO Vince Angotti says, \"We welcome our new shareholders and are appreciative that Three Arch was able to agree to the sale of its position to long-term shareholders that understand the potential value in AcelRx. We remain on track to achieve the remaining key milestones this year, with the expectation of another approved product in&nbsp;Europe&nbsp;and our first approved product in the&nbsp;U.S.&nbsp;with DSUVIA.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3359000\" data-linked=\"Leerink-led investors acquire Three Arch stake in AcelRx; shares up 7%\" data-tweet=\"$ACRX - Leerink-led investors acquire Three Arch stake in AcelRx; shares up 7% https://seekingalpha.com/news/3359000-leerink-led-investors-acquire-three-arch-stake-in-acelrx-shares-up-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3359000-leerink-led-investors-acquire-three-arch-stake-in-acelrx-shares-up-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358999\" data-ts=\"1527091596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RL\" target=\"_blank\">RL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358999-consumer-top-gainers-losers-of-12-05-pm-05-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:05 PM (05/23/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RL' title='Ralph Lauren Corporation'>RL</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/SYPR' title='Sypris Solutions, Inc.'>SYPR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358999\" data-linked=\"Consumer - Top Gainers / Losers as of 12:05 PM (05/23/2018)\" data-tweet=\"$RL $RL $SYPR - Consumer - Top Gainers / Losers as of 12:05 PM (05/23/2018) https://seekingalpha.com/news/3358999-consumer-top-gainers-losers-of-12-05-pm-05-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3358999-consumer-top-gainers-losers-of-12-05-pm-05-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358997\" data-ts=\"1527091479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNES\" target=\"_blank\">SNES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358997-senestech-partners-pestmaster\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SenesTech partners with Pestmaster</a></h4><ul>     <li>SenesTech (<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='green'>+3.9%</font>) and Pestmaster have developed a \"rapid rollout plan\" for the deployment of ContraPest in California, once approval of ContraPest is final.</li>     <li><a href=\"https://seekingalpha.com/pr/17171863-senestech-pestmaster-partner-bring-contrapest-california-pest-management\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3358997\" data-linked=\"SenesTech partners with Pestmaster\" data-tweet=\"$SNES - SenesTech partners with Pestmaster https://seekingalpha.com/news/3358997-senestech-partners-pestmaster?source=tweet\" data-url=\"https://seekingalpha.com/news/3358997-senestech-partners-pestmaster\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358993\" data-ts=\"1527091122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPP\" target=\"_blank\">WPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358993-advertising-stocks-slide-morgan-stanley-sounds-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advertising stocks slide as Morgan Stanley sounds warning</a></h4><ul>   <li>Margins are already cycle-high for advertising sector firms, and adding in growth that lags GDP makes a warning bell for the stocks, Morgan Stanley says.</li>    <li>The giants -- <a href='https://seekingalpha.com/symbol/WPP' title='WPP Plc'>WPP</a>, Publicis Groupe (<a href='https://seekingalpha.com/symbol/PUBGY' title='Publicis Groupe S.A. ADR'>OTCQX:PUBGY</a>), Interpublic Group (NYSE:<a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>) and Omnicom (NYSE:<a href='https://seekingalpha.com/symbol/OMC' title='Omnicom Group Inc.'>OMC</a>) -- look to be losing share in media spending, the firm says in a note. If the sector goes through a cyclical slowdown in 2019, then valuation multiples could re-test lows from late 2017, it says. (h/t Bloomberg)</li>    <li>WPP today is <font color='red'>down 4.7%</font>; Publicis is <font color='red'>off 2.7%</font>; Interpublic Group is <font color='red'>2.5% lower</font> (but closer to its 52-week high than its 52-week low); Omnicom is <font color='red'>4% lower</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358698-wsj-omnicom-takes-hsbc-media-account-struggling-wpp\" target=\"_blank\">WSJ: Omnicom takes HSBC media account from struggling WPP</a> (May. 22 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358993\" data-linked=\"Advertising stocks slide as Morgan Stanley sounds warning\" data-tweet=\"$WPP $WPP $PUBGY - Advertising stocks slide as Morgan Stanley sounds warning https://seekingalpha.com/news/3358993-advertising-stocks-slide-morgan-stanley-sounds-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3358993-advertising-stocks-slide-morgan-stanley-sounds-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358992\" data-ts=\"1527091036\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXMD\" target=\"_blank\">TXMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358992-therapeuticsmd-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TherapeuticsMD shares halted pending news</a></h4><ul><li>Nasdaq has <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">suspended trading</a> in TherapeuticsMD (<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a> <font color='green'>+2.2%</font>) pending the release of news, most likely related to its U.S. marketing application for TX-004HR for dyspareunia (action date May 29).</li><li><strong>Update</strong>: In a <a href=\"https://seekingalpha.com/pr/17172529-therapeuticsmd-comments-media-reports-regarding-txminus-004hr\" target=\"_blank\">statement</a>, the company says it has not received any communication from the FDA regarding its TX-004HR marketing application and still expects the announcement on May 29.</li><li><strong>Update</strong>: Shares will resume trading at 1:10 pm ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358992\" data-linked=\"TherapeuticsMD shares halted pending news\" data-tweet=\"$TXMD - TherapeuticsMD shares halted pending news https://seekingalpha.com/news/3358992-therapeuticsmd-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3358992-therapeuticsmd-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358990\" data-ts=\"1527090707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRSP\" target=\"_blank\">CRSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358990-trump-set-to-sign-right-to-try-bill-biotechs-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump set to sign &quot;right to try&quot; bill; biotechs rally</a></h4><ul><li>Many biotechs are in the green in early trade after the U.S. House of Representatives <a href=\"https://www.washingtonpost.com/national/health-science/right-to-try-legislation-heads-to-the-white-house/2018/05/22/64795536-5dea-11e8-a4a4-c070ef53f315_story.html?noredirect=on&amp;utm_term=.b2d78cb78239\" target=\"_blank\">voted in favor</a> of the Senate's version of \"right to try\" legislation yesterday. The bill, expected to be quickly signed into law by President Trump, will allow people with life-threatening illnesses to obtain unapproved drugs that have been vetted for safety in early-stage studies. In other words, the federal government will not interfere with a person's efforts to gain access to such a drug in this situation.</li><li>Critics say the law, which does not guarantee access the medications, will not have any appreciable effect on the status quo since supplies of investigational drugs are limited because developers earmark them for clinical trials.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color='green'>+7.3%</font>)(<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color='green'>+4.8%</font>)(<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a> <font color='green'>+5.2%</font>)(<a href='https://seekingalpha.com/symbol/UTHR' title='United Therapeutics Corporation'>UTHR</a> <font color='green'>+1.6%</font>)(<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='green'>+1.9%</font>)(<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color='green'>+2.2%</font>)(<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='green'>+1.1%</font>)(<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='green'>+0.8%</font>)(<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <font color='green'>+0.9%</font>)(<a href='https://seekingalpha.com/symbol/BIB' title='ProShares Ultra Nasdaq Biotechnology ETF'>BIB</a> <font color='green'>+0.9%</font>)(<a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a> <font color='green'>+2.5%</font>)(<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color='green'>+1.4%</font>)(<a href='https://seekingalpha.com/symbol/RCKT' title='Rocket Pharmaceuticals, Inc.'>RCKT</a> <font color='green'>+1.5%</font>)(<a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+9.4%</font>)(<a href='https://seekingalpha.com/symbol/VYGR' title='Voyager Therapeutics'>VYGR</a> <font color='green'>+2.8%</font>)(<a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a> <font color='green'>+0.8%</font>)(<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color='green'>+2.2%</font>)(<a href='https://seekingalpha.com/symbol/ONCE' title='Spark Therapeutics'>ONCE</a> <font color='green'>+4.6%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358990\" data-linked=\"Trump set to sign &quot;right to try&quot; bill; biotechs rally\" data-tweet=\"$CRSP $CRSP $EDIT - Trump set to sign &quot;right to try&quot; bill; biotechs rally https://seekingalpha.com/news/3358990-trump-set-to-sign-right-to-try-bill-biotechs-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/3358990-trump-set-to-sign-right-to-try-bill-biotechs-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>134&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358980\" data-ts=\"1527089517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XPLT\" target=\"_blank\">XPLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358980-xpel-technologies-announces-q1-strongest-quarter-in-company-s-history\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xpel Technologies announces Q1 as the strongest quarter in company\u2019s history</a></h4><ul><li>XPEL      Technologies      (<a href='https://seekingalpha.com/symbol/XPLT' title='Xpel Technologies Corp.'>OTC:XPLT</a> <font color='green'>+50.8%</font>)&nbsp;<a href=\"https://seekingalpha.com/pr/17171923-xpel-reports-record-first-quarter-revenue-growth-99_5-percent-25_2-million-eps-0_07\" target=\"_blank\">reports Q1</a>&nbsp;revenue growth of 99.5%      Y/Y &amp; 24.5% Q/Q to $25.2M.</li><li>Gross margin&nbsp;<font color='green'>improved 330 bps</font>&nbsp;to 29.7% &amp; EBITDA      margin&nbsp;<font color='green'>increased 905 bps&nbsp;</font>to 12.3%.</li><li>S,G&amp;A      expenses increased to $4.9M (+48.5% Y/Y) which was 19.4% of revenue, this increase was due mainly to increases in personnel, occupancy,      sales &amp; marketing &amp; information technology related costs to      support the ongoing growth of the business.</li><li>Cash &amp; equivalents of $3.4M (flat      Q/Q).</li><li>&ldquo;We remain      focused on continuing to drive profitable growth as we expand our presence      in both domestic &amp; international markets, capture new customers &amp;      grow our market share,&rdquo; said&nbsp;Mr. Ryan Pape, President &amp; CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358881-xpel-technologies-reports-q1-results\" target=\"_blank\">Xpel Technologies reports Q1 results</a> (May 23)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358980\" data-linked=\"Xpel Technologies announces Q1 as the strongest quarter in company\u2019s history\" data-tweet=\"$XPLT $XPEL - Xpel Technologies announces Q1 as the strongest quarter in company\u2019s history https://seekingalpha.com/news/3358980-xpel-technologies-announces-q1-strongest-quarter-in-company-s-history?source=tweet\" data-url=\"https://seekingalpha.com/news/3358980-xpel-technologies-announces-q1-strongest-quarter-in-company-s-history\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358976\" data-ts=\"1527089214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTA\" target=\"_blank\">CMTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358976-clementia-pharmas-palovarotene-shows-positive-effect-in-mid-stage-fop-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clementia Pharma&#39;s palovarotene shows positive effect in mid-stage FOP study</a></h4><ul><li>Thinly traded small cap Clementia Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CMTA' title='Clementia Pharmaceuticals'>CMTA</a> <font color='red'>-17.6%</font>) slumps on almost triple normal volume, albeit on turnover of only 132K shares, in apparent reaction to its <a href=\"https://seekingalpha.com/pr/17171622-clementia-reports-positive-phase-2-part-b-data-showing-treatment-palovarotene-significantly\" target=\"_blank\">announcement </a>of interim results from a Phase 2 clinical trial evaluating palovarotene in patients with fibrodysplasia ossificans progressiva &#40;FOP&#41;, a rare genetic disorder in which muscle and connective tissue are gradually replaced by bone.</li><li>Treatment with palovarotene, a small molecule retinoic acid receptor gamma agonist, reduced new bone growths at flare-up sites by 91% at week 12 compared to placebo and untreated flare-up sites from the company's natural history study. In evaluable patients, those with no new bone growths at week 12 also had no new bone growths at month 12, signaling a sustained benefit.</li><li>A Phase 3 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03312634?titles=move&amp;spons=clementia&amp;phase=2&amp;rank=1\" target=\"_blank\">MOVE</a>, is recruiting patients. The first data readout should happen in mid-2019.</li><li><a href=\"http://investor.clementiapharma.com/static-files/d36f1df9-e334-4e51-89d4-61e69b53683a\" target=\"_blank\">Slide presentation</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3317796-clementia-pharma-launches-late-stage-study-palovarotene-rare-extra-skeletal-bone-disorder\" target=\"_blank\">Clementia Pharma launches late-stage study of palovarotene in rare extra-skeletal bone disorder; shares up 2%</a> (Dec. 12, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358976\" data-linked=\"Clementia Pharma&#39;s palovarotene shows positive effect in mid-stage FOP study\" data-tweet=\"$CMTA - Clementia Pharma&#39;s palovarotene shows positive effect in mid-stage FOP study https://seekingalpha.com/news/3358976-clementia-pharmas-palovarotene-shows-positive-effect-in-mid-stage-fop-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3358976-clementia-pharmas-palovarotene-shows-positive-effect-in-mid-stage-fop-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358978\" data-ts=\"1527088327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AU\" target=\"_blank\">AU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358978-anglogold-to-cut-2k-jobs-shrinks-south-africa-footprint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AngloGold to cut 2K jobs as it shrinks South Africa footprint</a></h4><ul>     <li>AngloGold Ashanti (<a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color='red'>-2.1%</font>) says it will <a href=\"http://www.mining.com/anglogold-ashanti-axe-2000-jobs-shrinks-footprint-south-africa/\" target=\"_blank\">cut as many as 2K jobs</a> at its domestic South African operations as part a restructuring aimed at reducing losses.</li>     <li>AU, whose remaining South African assets are the Mponeng underground gold mine and a tailings treatment operation, says the move will affect employees across different categories and levels, including senior management.</li>     <li>AU currently employs ~8,200 people in South Africa, where mining companies are facing falling grades, rising costs, declining labor productivity and an uncertain regulatory environment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358978\" data-linked=\"AngloGold to cut 2K jobs as it shrinks South Africa footprint\" data-tweet=\"$AU - AngloGold to cut 2K jobs as it shrinks South Africa footprint https://seekingalpha.com/news/3358978-anglogold-to-cut-2k-jobs-shrinks-south-africa-footprint?source=tweet\" data-url=\"https://seekingalpha.com/news/3358978-anglogold-to-cut-2k-jobs-shrinks-south-africa-footprint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358972\" data-ts=\"1527087650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGR\" target=\"_blank\">AVGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358972-healthcare-top-5-gainers-losers-of-11-00-05-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (05/23/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+40%</font>. <a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CTXR' title='Citius Pharmaceuticals Inc.'>CTXR</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FWP' title='Forward Pharma'>FWP</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/PFNX' title='Pfenex'>PFNX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CMTA' title='Clementia Pharmaceuticals'>CMTA</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx'>ARDX</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358972\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (05/23/2018)\" data-tweet=\"$AVGR $AVGR $CARA - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (05/23/2018) https://seekingalpha.com/news/3358972-healthcare-top-5-gainers-losers-of-11-00-05-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3358972-healthcare-top-5-gainers-losers-of-11-00-05-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358955\" data-ts=\"1527086246\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLBAQ\" target=\"_blank\">WLBAQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358955-westmoreland-coalplus-28-after-securing-110m-in-new-financing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westmoreland Coal +28% after securing $110M in new financing</a></h4><ul>     <li>Westmoreland Coal (WLBA <font color='green'>+28%</font>) and Westmoreland Resource Partners (<a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a> <font color='green'>+173.1%</font>) skyrocket after announcing a <a href=\"https://seekingalpha.com/pr/17171284-westmoreland-secures-110-million-new-financing\" target=\"_blank\">new $110M financing commitment</a> from a group of existing secured creditors holding ~79% of its term loan and 79% of its senior secured notes.</li><li>WLB says the financing will provide additional liquidity and will fully repay both the San Juan term loan and the existing asset-based revolvers, simplifying its capital structure.</li>     <li>WLB also says the additional liquidity will provide more time to continue negotiations to develop a  comprehensive restructuring plan that will right-size its  capital structure and better ensure the company's long-term viability.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358955\" data-linked=\"Westmoreland Coal +28% after securing $110M in new financing\" data-tweet=\"$WLBAQ $WLBAQ $WMLP-OLD - Westmoreland Coal +28% after securing $110M in new financing https://seekingalpha.com/news/3358955-westmoreland-coalplus-28-after-securing-110m-in-new-financing?source=tweet\" data-url=\"https://seekingalpha.com/news/3358955-westmoreland-coalplus-28-after-securing-110m-in-new-financing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358928\" data-ts=\"1527083292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLUE\" target=\"_blank\">BLUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358928-bluebird-bios-lenti-d-breakthrough-therapy-for-rare-neurological-disorder-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bluebird bio&#39;s Lenti-D a Breakthrough Therapy for rare neurological disorder; shares up 2%</a></h4><ul><li>The FDA <a href=\"https://www.businesswire.com/news/home/20180523005335/en/FDA-Grants-Breakthrough-Therapy-Designation-Lenti-D%E2%84%A2-Treatment\" target=\"_blank\">designates </a>bluebird bio's (<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color='green'>+2%</font>) Lenti-D a Breakthrough Therapy for the treatment of <a href=\"https://www.bluebirdbio.com/patients-families/adrenoleukodystrophy/\" target=\"_blank\">cerebral adrenoleukodystrophy</a>, a rare disorder characterized by progressive neurological deterioration caused by the demyelination of nerve cells in the brain.</li><li>Breakthrough Therapy status provides for more intensive guidance from the FDA on development, the involvement of more senior agency personnel and a rolling review of the marketing application.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358928\" data-linked=\"Bluebird bio&#39;s Lenti-D a Breakthrough Therapy for rare neurological disorder; shares up 2%\" data-tweet=\"$BLUE - Bluebird bio&#39;s Lenti-D a Breakthrough Therapy for rare neurological disorder; shares up 2% https://seekingalpha.com/news/3358928-bluebird-bios-lenti-d-breakthrough-therapy-for-rare-neurological-disorder-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3358928-bluebird-bios-lenti-d-breakthrough-therapy-for-rare-neurological-disorder-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358925\" data-ts=\"1527082839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358925-frontierminus-3_8-failed-auction-sends-back-to-bondholder-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier -3.8% as failed auction sends it back to bondholder talks</a></h4><ul>   <li>Frontier Communications (NYSE:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) is stumbling out of the open, <font color='red'>down 3.8%</font>, as it's <a href=\"https://www.bloomberg.com/news/articles/2018-05-22/frontier-is-said-to-talk-with-bondholders-after-failed-auction\" target=\"_blank\">back in talks with bondholders</a> after an auction of Florida assets failed to garner a high enough price to go through.</li>    <li>It got multiple bids for landline assets in Florida -- part of the California/Texas/Florida assets it <a href=\"https://seekingalpha.com/news/3170997-verizon-frontier-close-10_5b-wireline-operation-sale\" target=\"_blank\">acquired from Verizon two years ago for $10.5B</a> -- but decided not to sell.</li><li>Proceeds were expected to go toward reducing a monster debt pile of $17.8B.</li>    <li>It's looking to unload the CTF package, but in pieces rather than the package deal it made with Verizon.</li>    <li>&ldquo;The problem is that they have a weak negotiating position,\" says Creditsights' Lindsay Gibbons. \"If they sold Florida for less than what they paid, it wouldn&rsquo;t look good and it puts a watermark on the other asset values.&rdquo;</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358925\" data-linked=\"Frontier -3.8% as failed auction sends it back to bondholder talks\" data-tweet=\"$FTR - Frontier -3.8% as failed auction sends it back to bondholder talks https://seekingalpha.com/news/3358925-frontierminus-3_8-failed-auction-sends-back-to-bondholder-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3358925-frontierminus-3_8-failed-auction-sends-back-to-bondholder-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358917\" data-ts=\"1527081993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMTI\" target=\"_blank\">RMTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358917-rockwell-medical-shares-halted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rockwell Medical shares halted</a></h4><ul><li>Nasdaq has <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">suspended trading</a> in Rockwell Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/RMTI' title='Rockwell Medical, Inc.'>RMTI</a>) pending the release of news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358917\" data-linked=\"Rockwell Medical shares halted\" data-tweet=\"$RMTI - Rockwell Medical shares halted https://seekingalpha.com/news/3358917-rockwell-medical-shares-halted?source=tweet\" data-url=\"https://seekingalpha.com/news/3358917-rockwell-medical-shares-halted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358915\" data-ts=\"1527081837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABWN\" target=\"_blank\">ABWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358915-airborne-wireless-networkminus-1_9-on-9000-unit-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Airborne Wireless Network -1.9% on 9,000-unit offering</a></h4><ul>   <li>Airborne Wireless Network (<a href='https://seekingalpha.com/symbol/ABWN' title='Airborne Wireless Network'>OTCPK:ABWN</a>) is <font color='red'>1.9% lower</font> after a filing last night to <a href=\"https://seekingalpha.com/filing/4036748\" target=\"_blank\">offer 9,000 units</a>.</li>    <li>Each unit consists of one share of series A convertible preferred stock, along with series 1, series 2 and series 3 warrants to each buy a share of series A convertible preferred stock.</li>    <li>The units are being offered at $1,000 each; the warrants are exercisable at an initial price of $1,000/share of series A convertible preferred stock.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358915\" data-linked=\"Airborne Wireless Network -1.9% on 9,000-unit offering\" data-tweet=\"$ABWN - Airborne Wireless Network -1.9% on 9,000-unit offering https://seekingalpha.com/news/3358915-airborne-wireless-networkminus-1_9-on-9000-unit-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3358915-airborne-wireless-networkminus-1_9-on-9000-unit-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358914\" data-ts=\"1527081767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFNX\" target=\"_blank\">PFNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358914-pfenex-prices-stock-offering-5_50-shares-down-16-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pfenex prices stock offering at $5.50; shares down 16% premarket</a></h4><ul><li>Thinly traded micro cap Pfenex (NYSEMKT:<a href='https://seekingalpha.com/symbol/PFNX' title='Pfenex'>PFNX</a>) is down&nbsp;<font color='red'>16%</font>&nbsp;premarket on average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17172196-pfenex-announces-pricing-offering-6800-000-shares-common-stock\" target=\"_blank\">public offering</a> of 6.8M shares of common stock at $5.50 per share. Underwriters over-allotment is an additional 1.02M shares. Closing date is May 25.</li><li>Yesterday's close was $6.90.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358914\" data-linked=\"Pfenex prices stock offering at $5.50; shares down 16% premarket\" data-tweet=\"$PFNX - Pfenex prices stock offering at $5.50; shares down 16% premarket https://seekingalpha.com/news/3358914-pfenex-prices-stock-offering-5_50-shares-down-16-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3358914-pfenex-prices-stock-offering-5_50-shares-down-16-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358912\" data-ts=\"1527081697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGR\" target=\"_blank\">AVGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358912-premarket-gainers-of-9-05-05-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (05/23/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+54%</font>&nbsp;on FDA <a href=\"https://seekingalpha.com/news/3358894-avinger-receives-fda-clearance-pantheris-device-shares-ahead-47-percent-premarket\" target=\"_blank\">clearance</a> for Pantheris device.</li><li><a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='green'>+25%</font>&nbsp;to <a href=\"https://seekingalpha.com/pr/17171863-senestech-pestmaster-partner-bring-contrapest-california-pest-management\" target=\"_blank\">partner</a> with Pestmaster to Bring ContraPest to California Pest Management.</li><li><a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a> <font color='green'>+17%</font>&nbsp;on&nbsp;out-licenses Korsuva to Vifor Fresenius for up to $520M.</li><li><a href='https://seekingalpha.com/symbol/TIF' title='Tiffany & Co.'>TIF</a> <font color='green'>+15%</font>&nbsp;on Q1&nbsp;<a href=\"https://seekingalpha.com/news/3358815-tiffany-beats-0_31-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a> <font color='green'>+12%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17171662-dropcar-expands-san-francisco\" target=\"_blank\">expanding</a> into San Francisco.</li><li><a href='https://seekingalpha.com/symbol/AEL' title='American Equity Investment Life Holding Company'>AEL</a> <font color='green'>+8%</font>&nbsp;on sale <a href=\"https://seekingalpha.com/news/3358699-american-equity-nearly-8-percent-sale-chatter\" target=\"_blank\">chatter</a>.</li><li><a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a> <font color='green'>+6%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3358885-vaalco-energy-plus-12-percent-eliminating-outstanding-debt-ifc\" target=\"_blank\">eliminating</a> outstanding debt with IFC.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358912\" data-linked=\"Premarket Gainers as of 9:05 am (05/23/2018)\" data-tweet=\"$AVGR $AVGR $SNES - Premarket Gainers as of 9:05 am (05/23/2018) https://seekingalpha.com/news/3358912-premarket-gainers-of-9-05-05-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3358912-premarket-gainers-of-9-05-05-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358908\" data-ts=\"1527081452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRGB\" target=\"_blank\">RRGB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358908-premarket-losers-of-9-10-5-23-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:10 am (5/23/2018)</a></h4><ul> <li><a href='https://seekingalpha.com/symbol/RRGB' title='Red Robin Gourmet Burgers, Inc.'>RRGB</a>&nbsp;<font color='red'>-20%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3358706-red-robin-gourmet-burgers-misses-0_06-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/PFNX' title='Pfenex'>PFNX</a>&nbsp;<font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3358729-pfenex-readies-stock-offering\" target=\"_blank\">announcing</a> common stock offering.</li><li><a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx'>ARDX</a>&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3358836-ardelyx-9-percent-pricing-common-stock-offering\" target=\"_blank\">pricing</a> common stock offering.</li><li><a href='https://seekingalpha.com/symbol/FWP' title='Forward Pharma'>FWP</a> <font color='red'>-14%</font>.</li><li><a href='https://seekingalpha.com/symbol/TCS' title='The Container Store Group, Inc.'>TCS</a>&nbsp;<font color='red'>-13%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3358708-container-store-misses-0_05-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/TKC' title='Turkcell Iletisim Hizmetleri A.S.'>TKC</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3358908\" data-linked=\"Premarket Losers as of 9:10 am (5/23/2018)\" data-tweet=\"$RRGB $RRGB $PFNX - Premarket Losers as of 9:10 am (5/23/2018) https://seekingalpha.com/news/3358908-premarket-losers-of-9-10-5-23-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3358908-premarket-losers-of-9-10-5-23-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358893\" data-ts=\"1527080668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358893-10-year-yield-heads-back-to-3-on-macro-shudders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">10-year yield heads back to 3% on macro shudders</a></h4><ul><li>Europe's having one of its worst days in weeks (the Stoxx 600 is&nbsp;<font color='red'>down 1%</font>), and S&amp;P 500 futures are<font color='red'> lower by 0.6%</font>.</li><li>Among the easy excuses for selling: Amped up trade-war talk, and the idea that the Fed rate hike cycle is beginning to expose cracks in the goldilocks scenario.</li><li>Alongside the crumbling in Argentina's peso, we now have the Turkish lira <a href=\"https://seekingalpha.com/news/3358787-turkeys-lira-slides-new-record-low\" target=\"_blank\">plunging to an</a> all-time low. Moving past emerging markets, the rout in Italian government paper has picked up steam, with 10-year BTP yields up nearly 12 basis points today to 2.44% - this as government bond yields in the rest of the developed world head sharply lower.</li><li>In the U.S., the 10-year Treasury yield earlier reached as low as 3%. Currently, it's off more than four basis points to 3.02%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='green'>+0.7%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='red'>-1.4%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>, <a href='https://seekingalpha.com/symbol/TMV' title='Direxion Daily 20+ Year Treasury Bear 3x Shares ETF'>TMV</a>, <a href='https://seekingalpha.com/symbol/TBF' title='ProShares Short 20+ Year Treasury ETF'>TBF</a>, <a href='https://seekingalpha.com/symbol/EDV' title='Vanguard Extended Duration Treasury ETF'>EDV</a>, <a href='https://seekingalpha.com/symbol/TMF' title='Direxion Daily 30-Year Treasury Bull 3x Shares ETF'>TMF</a>, <a href='https://seekingalpha.com/symbol/TTT' title='ProShares UltraPro Short 20+ Year Treasury ETF'>TTT</a>, <a href='https://seekingalpha.com/symbol/ZROZ' title='PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF'>ZROZ</a>, <a href='https://seekingalpha.com/symbol/VGLT' title='Vanguard Long-Term Treasury ETF'>VGLT</a>, <a href='https://seekingalpha.com/symbol/TLH' title='iShares 10-20 Year Treasury Bond ETF'>TLH</a>, <a href='https://seekingalpha.com/symbol/UBT' title='ProShares Ultra 20+ Year Treasury ETF'>UBT</a>, <a href='https://seekingalpha.com/symbol/SPTL' title='SPDR Portfolio Long Term Treasury ETF'>SPTL</a>, <a href='https://seekingalpha.com/symbol/DLBS' title='iPath U.S. Treasury Long Bond Bear ETN'>DLBS</a>, <a href='https://seekingalpha.com/symbol/VUSTX' title='Vanguard Long Term Treasury Fund Inv'>VUSTX</a>, <a href='https://seekingalpha.com/symbol/TYBS' title='Direxion Daily 20+ Year Treasury Bear 1x Shares ETF'>TYBS</a>, <a href='https://seekingalpha.com/symbol/DLBL' title='iPath U.S. Treasury Long Bond Bull ETN'>DLBL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3358893\" data-linked=\"10-year yield heads back to 3% on macro shudders\" data-tweet=\"$TLT $TBT $TMV - 10-year yield heads back to 3% on macro shudders https://seekingalpha.com/news/3358893-10-year-yield-heads-back-to-3-on-macro-shudders?source=tweet\" data-url=\"https://seekingalpha.com/news/3358893-10-year-yield-heads-back-to-3-on-macro-shudders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358901\" data-ts=\"1527080593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRN\" target=\"_blank\">CTRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358901-on-citi-trends-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Citi Trends&#39; Q1 results</a></h4><ul><li>Citi Trends (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRN' title='Citi Trends, Inc.'>CTRN</a>) reports comparable-store sales rose 2.1% in <a href=\"https://seekingalpha.com/pr/17171638-citi-trends-announces-first-quarter-2018-results-declares-quarterly-dividend\" target=\"_blank\">Q1</a>.</li><li>Gross margin rate decreased 350 bps to 35.3%.</li><li>SG&amp;A expense rate up 120 bps to 31.5%.</li><li>GAAP operating margin rate grew 40 bps to 6.8% for the quarter.</li><li>Inventory +0.6% to $$125.33M.</li><li>Store count +15 Y/Y to 553.</li><li>The Company repurchased 86K shares at $2.7M during the quarter.</li><li>The Company reaffirmed previous Diluted EPS guidance of $1.55 to $1.70 for FY2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358816-citi-trends-misses-0_07-beats-revenue\" target=\"_blank\">Citi Trends misses by $0.07, beats on revenue</a> (May 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358901\" data-linked=\"More on Citi Trends&#39; Q1 results\" data-tweet=\"$CTRN - More on Citi Trends&#39; Q1 results https://seekingalpha.com/news/3358901-on-citi-trends-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3358901-on-citi-trends-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358900\" data-ts=\"1527080467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSM\" target=\"_blank\">TSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358900-bloomberg-tsmc-mass-producing-7nm-chips-for-apples-iphones\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: TSMC mass producing 7nm chips for Apple&#39;s iPhones</a></h4><ul><li>Taiwan Semiconductor Manufacturing Co. (NYSE:<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a>) has started mass production of its next-gen 7nm processors for the new Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) iPhones launching this year, according to <a href=\"https://www.bloomberg.com/news/articles/2018-05-23/apple-partner-tsmc-is-said-to-start-making-chips-for-new-iphones\" target=\"_blank\">Bloomberg sources</a>.</li><li>The processor will likely be called the A12 chip and will have a smaller and more efficient performance than the 10nm chips in current iPhones.</li><li>TSMC announced the 7nm mass production in April but didn&rsquo;t disclose a partner.</li><li>Taiwan Semiconductor shares are&nbsp;<font color='red'>down 1%</font>&nbsp;premarket to $39.25.</li><li>Post updated to correct ticker.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358900\" data-linked=\"Bloomberg: TSMC mass producing 7nm chips for Apple&#39;s iPhones\" data-tweet=\"$TSM $TSM $AAPL - Bloomberg: TSMC mass producing 7nm chips for Apple&#39;s iPhones https://seekingalpha.com/news/3358900-bloomberg-tsmc-mass-producing-7nm-chips-for-apples-iphones?source=tweet\" data-url=\"https://seekingalpha.com/news/3358900-bloomberg-tsmc-mass-producing-7nm-chips-for-apples-iphones\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358894\" data-ts=\"1527080281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGR\" target=\"_blank\">AVGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358894-avinger-receives-fda-clearance-for-pantheris-device-shares-ahead-47-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avinger receives FDA clearance for Pantheris device; shares ahead 47% premarket</a></h4><ul><li>Avinger (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a>) has <a href=\"https://seekingalpha.com/pr/17171924-avinger-receives-fda-clearance-next-generation-pantheris-device\" target=\"_blank\">received</a> 510(k) clearance from the FDA for its next generation <a href=\"http://avinger.com/devices/pantheris/\" target=\"_blank\">Pantheris Lumivascular atherectomy system</a>, the first-ever image-guided atherectomy device for the treatment of <a href=\"https://medlineplus.gov/peripheralarterialdisease.html\" target=\"_blank\">peripheral artery disease</a> &#40;PAD&#41;.</li><li>Lumivascular is the only technology that combines real-time intravascular imaging with highly effective catheters for the treatment of PAD.</li>   <li>The Company intends to launch two versions of this product (standard and extended length nosecone) into initial sites in the U.S. immediately, and plans to incorporate the new design into the INSIGHT IDE clinical trial currently in progress.</li><li>Shares are up&nbsp;<font color='green'>47%</font>&nbsp;premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3358894\" data-linked=\"Avinger receives FDA clearance for Pantheris device; shares ahead 47% premarket\" data-tweet=\"$AVGR - Avinger receives FDA clearance for Pantheris device; shares ahead 47% premarket https://seekingalpha.com/news/3358894-avinger-receives-fda-clearance-for-pantheris-device-shares-ahead-47-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3358894-avinger-receives-fda-clearance-for-pantheris-device-shares-ahead-47-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358886\" data-ts=\"1527079307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RL\" target=\"_blank\">RL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358886-ralph-lauren-positive-on-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ralph Lauren positive on earnings beat</a></h4><ul><li>Ralph Lauren (NYSE:<a href='https://seekingalpha.com/symbol/RL' title='Ralph Lauren Corporation'>RL</a>)&nbsp;reports revenue fell 7% on a constant currency basis in <a href=\"https://seekingalpha.com/pr/17171864-ralph-lauren-reports-fourth-quarter-full-year-fiscal-2018-results\" target=\"_blank\">Q4</a>.</li><li>North America revenue squeezed 14% to $759M (-14%&nbsp;on a constant currency basis) due to lower sales in the wholesale channel, driven by distribution and brand exits, strategic reductions in shipments and promotional activity to increase quality of sales, as well as lower consumer demand.</li><li>Europe revenue increase 13% to $420M (-1%&nbsp;on a constant currency basis).</li><li>Asia revenue up 17% to $257M (+11% on a constant currency basis).</li><li>Adjusted gross margin rate improved 440 bps to 59.8%.</li><li>Adjusted operating margin rate slipped 110 bps to 5.6%.</li><li><strong>Q1 Guidance</strong>: Net revenues:&nbsp;flat to down slightly in constant currency; Operating margin rate:&nbsp;up slightly in constant currency; Tax rate: ~18%.</li><li><strong>FY2019 Guidance</strong>:&nbsp;Net revenues:&nbsp;decrease low single-digits in constant currency; Operating margin rate:&nbsp;up slightly in constant currency; Tax rate: ~22%; Capex: ~$275M.</li><li>RL&nbsp;<font color='green'>+3.34%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358865-ralph-lauren-beats-0_07-beats-revenue\" target=\"_blank\">Ralph Lauren beats by $0.07, beats on revenue</a> (May 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358886\" data-linked=\"Ralph Lauren positive on earnings beat\" data-tweet=\"$RL - Ralph Lauren positive on earnings beat https://seekingalpha.com/news/3358886-ralph-lauren-positive-on-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3358886-ralph-lauren-positive-on-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358885\" data-ts=\"1527078979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGY\" target=\"_blank\">EGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358885-vaalco-energyplus-12-after-eliminating-outstanding-debt-ifc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vaalco Energy +12% after eliminating outstanding debt with IFC</a></h4><ul>     <li>Vaalco Energy (NYSE:<a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a>) <font color='green'>+12.6%</font> premarket after announcing it <a href=\"https://seekingalpha.com/pr/17171338-vaalco-energy-inc-announces-early-repayment-ifc-debt-workover-program-now-underway\" target=\"_blank\">paid off the outstanding $7M balance</a> on its amended term loan agreement with the International Finance Corp.</li>     <li>EGY says it now has no debt on the balance sheet for the first time since 2014 and is realizing \"significant\" cash flow generation due to the strong improvement in Brent oil prices.</li>     <li>EGY also says it began workover operations last week to restore production to two wells currently shut-in on the Avouma platform, and estimates production of ~750 net bbl/day of oil may be restored if both workovers are successful.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358885\" data-linked=\"Vaalco Energy +12% after eliminating outstanding debt with IFC\" data-tweet=\"$EGY - Vaalco Energy +12% after eliminating outstanding debt with IFC https://seekingalpha.com/news/3358885-vaalco-energyplus-12-after-eliminating-outstanding-debt-ifc?source=tweet\" data-url=\"https://seekingalpha.com/news/3358885-vaalco-energyplus-12-after-eliminating-outstanding-debt-ifc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358882\" data-ts=\"1527078876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGIO\" target=\"_blank\">AGIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358882-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Agios Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a>) initiated with Buy rating and $117 (36% upside) price target at Citigroup.</li><li>HealthEquity (NASDAQ:<a href='https://seekingalpha.com/symbol/HQY' title='HealthEquity'>HQY</a>) initiated with Buy rating and $83 (11% upside) price target at BofA/Merrill Lynch.</li><li>Vanda Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VNDA' title='Vanda Pharmaceuticals Inc.'>VNDA</a>) initiated with Buy rating and $26 (57% upside) price target at Citigroup.</li><li>VolitionRx Limited (NYSEMKT:<a href='https://seekingalpha.com/symbol/VNRX' title='VolitionRX Ltd'>VNRX</a>) initiated with Outperform rating and $7 (213% upside) price target at Oppenheimer.</li><li>Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>) upgraded to Outperform with a $102 (32% upside) price target at Bernstein. Analysts say its current valuation reflects the \"worst case outcome\" for the entry of generic competition to Revlimid in April 2020. Four potential product approvals in the next 24 months could boost valuation and change investor sentiment. Shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li><li>LTC Properties (NYSE:<a href='https://seekingalpha.com/symbol/LTC' title='LTC Properties Inc.'>LTC</a>) downgraded to Underperform with a $38 (4% downside risk) price target at RBC.</li><li>MedEquities Realty Trust (NYSE:<a href='https://seekingalpha.com/symbol/MRT' title='MedEquities Realty Trust, Inc.'>MRT</a>) downgraded to Sector Perform with an $11 (7% upside) price target at RBC.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358882\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$AGIO $AGIO $HQY - Premarket analyst action - healthcare https://seekingalpha.com/news/3358882-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3358882-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358876\" data-ts=\"1527078033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESPR\" target=\"_blank\">ESPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358876-esperion-therapeutics-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Esperion Therapeutics halted pending news</a></h4><ul><li>Nasdaq has <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">suspended trading</a> in Esperion Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ESPR' title='Esperion Therapeutics'>ESPR</a>) pending the release of news.</li><li><strong>Update</strong>: The company's bempedoic acid was <a href=\"https://seekingalpha.com/pr/17171891-esperion-announces-third-pivotal-phase-3-study-bempedoic-acid-meets-primary-endpoint\" target=\"_blank\">successful</a> in the third of five pivotal Phase 3 studies (Study 3 or 1002-046). High-risk patients with atherosclerotic cardiovascular disease &#40;ASCVD&#41; or at high-risk for ASCVD with hypercholesterolemia (elevated blood cholesterol) inadequately controlled with maximally tolerated background therapy experienced significant lowering of LDL-C (\"bad\" cholesterol) after 12 weeks of treatment.</li><li>The study met the primary endpoint of demonstrating a statistically significant reduction in LDL-C versus placebo at week 12. Specifically, patients in the treatment group showed a 23% drop in bad cholesterol compared to a decrease of 1% for placebo (p&lt;0.001). At week 24, bempidoic acid also demonstrated its superiority to control with a 26% reduction in LDL-C versus 2% for placebo.</li><li>Patients in the treatment group experienced a 25% reduction in C-reactive protein, an inflammation biomarker, compared to an increase of 3% for control (p&lt;0.001).</li><li>Complete results will be submitted for presentation at an upcoming medical conference.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358876\" data-linked=\"Esperion Therapeutics halted pending news\" data-tweet=\"$ESPR - Esperion Therapeutics halted pending news https://seekingalpha.com/news/3358876-esperion-therapeutics-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3358876-esperion-therapeutics-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358871\" data-ts=\"1527077698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMTI\" target=\"_blank\">RMTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358871-rockwell-medical-announces-ceo-transition-shares-ahead-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rockwell Medical announces CEO transition; shares ahead 9% premarket</a></h4><ul><li>Rockwell Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/RMTI' title='Rockwell Medical, Inc.'>RMTI</a>) <a href=\"https://seekingalpha.com/pr/17171448-rockwell-medical-announces-ceo-transition\" target=\"_blank\">announces</a> that its Board of Directors has formed a Special Transition Committee&nbsp;to provide board-level oversight over the strategic direction and day-to-day operations. The Committee will comprise independent directors&nbsp;Ben Wolin,&nbsp;Lisa Colleran&nbsp;and&nbsp;John Cooper.</li><li>Also, the Company's President and CEO, Robert Chioini, has been terminated from his positions, effective immediately.&nbsp;Mr. Chioini has also resigned as a member of the Board. A formal search process to identify a permanent CEO is initiated.</li><li>Shares are up&nbsp;<font color='green'>9%</font>&nbsp;premarket.</li><li><strong>Update</strong>: In a <a href=\"https://seekingalpha.com/pr/17172428-rockwell-medical-ceo-issues-press-release\" target=\"_blank\">statement </a>issued by the company on behalf of Mr. Chioini, he stated that he called an emergency board meeting yesterday to address a shareholder demand letter requesting an independent investigation into alleged breaches of fiduciary duties and possible violations of securities and other laws by certain directors. The directors under question voted to fire him but the non-conflicted directors believed that the vote was not effective since the action was not the purpose of the special meeting. As such, he will continue to serve as CEO consistent with his employment contract. The internal investigation is proceeding under the direction of two non-conflicted directors. Also, contrary to an <a href=\"https://www.sec.gov/Archives/edgar/data/1041024/000110465918035231/a18-14218_28k.htm\" target=\"_blank\">announcement </a>from the Chairman, CFO Thomas Klema has not been terminated and continues to fulfill his responsibilities.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3358871\" data-linked=\"Rockwell Medical announces CEO transition; shares ahead 9% premarket\" data-tweet=\"$RMTI - Rockwell Medical announces CEO transition; shares ahead 9% premarket https://seekingalpha.com/news/3358871-rockwell-medical-announces-ceo-transition-shares-ahead-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3358871-rockwell-medical-announces-ceo-transition-shares-ahead-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358869\" data-ts=\"1527077298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358869-comcast-near-all-cash-offer-for-parts-of-fox\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comcast: Near all-cash offer for parts of Fox</a></h4><ul><li>Ahead of special meetings for Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>) shareholders to consider a sale to Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>), Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) says it's in \"advanced stages\" of a competing offer for those businesses.</li><li>Any offer, says Comcast, would be all-cash and at a premium to the current Disney bid.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17171768-b-comcast-b-considering-superior-cash-offer-acquire-twenty-first-century-fox-spinoff-new-fox\" target=\"_blank\">Press Release</a></li><li>FOX&nbsp;<font color='green'>+1.3%</font>, FOXA&nbsp;<font color='green'>+0.4%</font>, DIS&nbsp;<font color='red'>-0.5%</font>, CMCSA&nbsp;<font color='red'>-1.6%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3358869\" data-linked=\"Comcast: Near all-cash offer for parts of Fox\" data-tweet=\"$FOX $FOX $FOXA - Comcast: Near all-cash offer for parts of Fox https://seekingalpha.com/news/3358869-comcast-near-all-cash-offer-for-parts-of-fox?source=tweet\" data-url=\"https://seekingalpha.com/news/3358869-comcast-near-all-cash-offer-for-parts-of-fox\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>75&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358863\" data-ts=\"1527076921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANW\" target=\"_blank\">ANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358863-aegean-marineplus-3_5-after-launching-strategic-operational-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegean Marine +3.5% after launching strategic, operational review</a></h4><ul>     <li>Aegean Marine Petroleum (<a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a>)&nbsp;<font color='green'>+3.5%</font> premarket after announcing a <a href=\"https://seekingalpha.com/pr/17171317-aegean-marine-petroleum-network-inc-provides-business-updates\" target=\"_blank\">strategic and operational review</a>, including \"an evaluation of the company&rsquo;s physical assets, existing footprint, and the capital efficiency of every business activity in which the company is engaged and each port in which it operates.\"</li>     <li>ANW appoints former Morgan Stanley executive Donald Moore as Chairman and adds three new independent directors.</li>     <li>ANW also reports \"stable\" preliminary Q1 operating results as network volumes and gross spreads were largely consistent with Q4 2017, and says it continues to  generate positive cash flow.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358863\" data-linked=\"Aegean Marine +3.5% after launching strategic, operational review\" data-tweet=\"$ANW - Aegean Marine +3.5% after launching strategic, operational review https://seekingalpha.com/news/3358863-aegean-marineplus-3_5-after-launching-strategic-operational-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3358863-aegean-marineplus-3_5-after-launching-strategic-operational-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358848\" data-ts=\"1527075617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDT\" target=\"_blank\">MDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358848-medtronics-symplicity-spyral-system-shows-treatment-effect-in-hypertension-study-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medtronic&#39;s Symplicity Spyral system shows treatment effect in hypertension study; shares up 1% premarket</a></h4><ul><li>Medtronic (NYSE:<a href='https://seekingalpha.com/symbol/MDT' title='Medtronic plc'>MDT</a>) is up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume in response to its <a href=\"http://newsroom.medtronic.com/phoenix.zhtml?c=251324&amp;p=irol-newsArticle&amp;ID=2350364\" target=\"_blank\">announcement </a>of positive preliminary results from the SPYRAL HTN-ON MED study evaluating its Symplicity Spyral renal denervation &#40;RDN&#41; system in patients with high blood pressure receiving anti-hypertension medications. The data were presented at EuroPCR in Paris and published in <em>The Lancet</em>.</li><li>At month 6, patients receiving treatment with Symplicity Spyral experienced an average reduction in 24-hour mean systolic (blood pressure during contraction of the heart) ambulatory blood pressure &#40;ABPM&#41; of 9 mm Hg, 7.4 mm Hg greater than sham control (p=0.005). The reduction in diastolic (blood pressure between heart beats) ABPM was 6.0 mm Hg, 4.1 mm Hg greater than sham control (p=0.029).</li><li>The positive results represent a win for the company. An earlier study, <a href=\"https://www.medscape.com/viewarticle/819148\" target=\"_blank\">SYMPLICITY HTN-3</a>, failed to achieve the primary endpoint.</li><li>Renal denervation is a minimally invasive catheter-based procedure that regulates the over-activity of nerves leading to and from the kidney which helps to lower blood pressure in patients inadequately controlled with medication.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358848\" data-linked=\"Medtronic&#39;s Symplicity Spyral system shows treatment effect in hypertension study; shares up 1% premarket\" data-tweet=\"$MDT - Medtronic&#39;s Symplicity Spyral system shows treatment effect in hypertension study; shares up 1% premarket https://seekingalpha.com/news/3358848-medtronics-symplicity-spyral-system-shows-treatment-effect-in-hypertension-study-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3358848-medtronics-symplicity-spyral-system-shows-treatment-effect-in-hypertension-study-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358846\" data-ts=\"1527075334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CY\" target=\"_blank\">CY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358846-cowen-initiates-cypress-semi-29-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen initiates Cypress Semi at 29% upside</a></h4><ul><li>        Cowen<a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Cowen+Starts+Cypress+Semi+%28CY%29+at+Outperform/14225303.html\" target=\"_blank\"> initiates</a> Cypress Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/CY' title='Cypress Semiconductor Corporation'>CY</a>) with an Outperform rating and a $21 price target.</li><li>               The new target represents a 29% upside to yesterday&rsquo;s close.&nbsp;</li><li>               Cypress Semi shares are&nbsp;<font color='green'>up 0.3%</font>&nbsp;premarket to $16.35. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3358846\" data-linked=\"Cowen initiates Cypress Semi at 29% upside\" data-tweet=\"$CY - Cowen initiates Cypress Semi at 29% upside https://seekingalpha.com/news/3358846-cowen-initiates-cypress-semi-29-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3358846-cowen-initiates-cypress-semi-29-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358841\" data-ts=\"1527074886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYOK\" target=\"_blank\">MYOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358841-myokardia-prices-common-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MyoKardia prices common stock offering</a></h4><ul> <li>MyoKardia (NASDAQ:<a href='https://seekingalpha.com/symbol/MYOK' title='MyoKardia'>MYOK</a>) <a href=\"https://seekingalpha.com/pr/17171463-myokardia-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices</a> its public offering of 3.75M shares of common stock at a price of $49.00 per share.</li><li>Underwriters over-allotment is an&nbsp;additional 562.5K shares.</li>   <li>Net proceeds will be used to fund R&amp;D activities for its development programs, for working capital and other general corporate purposes.</li><li>Shares are down&nbsp;<font color='red'>1%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358357-myokardia-launches-stock-offering-shares-3-percent-hours\" target=\"_blank\">MyoKardia launches stock offering; shares down 3% after hours</a> (May 21)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3358841\" data-linked=\"MyoKardia prices common stock offering\" data-tweet=\"$MYOK - MyoKardia prices common stock offering https://seekingalpha.com/news/3358841-myokardia-prices-common-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3358841-myokardia-prices-common-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358840\" data-ts=\"1527074844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QRVO\" target=\"_blank\">QRVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358840-qorvo-approves-1b-repurchase-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qorvo approves $1B repurchase program</a></h4><ul><li>        Qorvo&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a>) board <a href=\"https://seekingalpha.com/pr/17171705-qorvo-announces-1-billion-share-repurchase-program\" target=\"_blank\">approves</a> an up to $1B repurchase of common stock.</li><li>                  The new program includes approximately $126M remaining from a prior program.    </li><li>               Qorvo shares are&nbsp;<font color='green'>up 0.9%</font>&nbsp;premarket to $81.50. &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3358840\" data-linked=\"Qorvo approves $1B repurchase program\" data-tweet=\"$QRVO - Qorvo approves $1B repurchase program https://seekingalpha.com/news/3358840-qorvo-approves-1b-repurchase-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3358840-qorvo-approves-1b-repurchase-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358836\" data-ts=\"1527074540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARDX\" target=\"_blank\">ARDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358836-ardelyx-down-9-on-pricing-common-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ardelyx down 9% on pricing common stock offering</a></h4><ul> <li>Ardelyx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx'>ARDX</a>) <a href=\"https://seekingalpha.com/pr/17171416-ardelyx-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices</a> its public offering of 12.5M shares of common stock at a price of $4.00 per share yielding gross proceeds of $50M.</li><li>Underwriters over-allotment is an&nbsp;additional 1.875M shares.</li>                  <li>Net proceeds will be used&nbsp;to support its clinical development and pre-commercialization efforts for tenapanor, R&amp;D efforts for its RDX013 program and for general corporate purposes and working capital.</li>  <li>Closing date is May 25.</li><li>Shares are down&nbsp;<font color='red'>9%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358391-ardelyx-readies-stock-offering-shares-8-percent-hours\" target=\"_blank\">Ardelyx readies stock offering; shares down 8% after hours</a> (May 21)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3358836\" data-linked=\"Ardelyx down 9% on pricing common stock offering\" data-tweet=\"$ARDX - Ardelyx down 9% on pricing common stock offering https://seekingalpha.com/news/3358836-ardelyx-down-9-on-pricing-common-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3358836-ardelyx-down-9-on-pricing-common-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358835\" data-ts=\"1527074516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIMO\" target=\"_blank\">SIMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358835-cowen-initiates-silicon-motion-6-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen initiates Silicon Motion at 6% upside</a></h4><ul><li>        Cowen <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Cowen+Starts+Silicon+Motion+Technology+%28SIMO%29+at+Market+Perform/14225340.html\" target=\"_blank\">initiates</a> Silicon Motion (NASDAQ:<a href='https://seekingalpha.com/symbol/SIMO' title='Silicon Motion Technology Corporation'>SIMO</a>) with a Market Perform price target and $53 price target.</li><li>               Target represents a 6% upside to yesterday&rsquo;s close.&nbsp;</li><li>               Silicon Motion shares are&nbsp;<font color='green'>up 0.4%</font>&nbsp;premarket to $50.07.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3358835\" data-linked=\"Cowen initiates Silicon Motion at 6% upside\" data-tweet=\"$SIMO - Cowen initiates Silicon Motion at 6% upside https://seekingalpha.com/news/3358835-cowen-initiates-silicon-motion-6-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3358835-cowen-initiates-silicon-motion-6-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358830\" data-ts=\"1527074175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHRS\" target=\"_blank\">CHRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358830-coherus-down-3-on-pricing-common-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coherus down 3% on pricing common stock offering</a></h4><ul> <li>Coherus BioSciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a>) <a href=\"https://seekingalpha.com/pr/17171453-coherus-prices-public-offering-common-stock\" target=\"_blank\">prices</a> its public offering of 5.17M shares of common stock at a price of $14.50 per share.</li><li>Underwriters over-allotment is an&nbsp;additional 775.86K shares.</li>   <li>Net proceeds will be used to support the launch of&nbsp;CHS-1701, for clinical trial activities and for working capital and general corporate purposes.</li>  <li>Closing date is May 25.</li><li>Shares are down&nbsp;<font color='red'>3%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358604-coherus-announces-proposed-public-offering-common-stock\" target=\"_blank\">Coherus announces proposed public offering of common stock</a> (May 22)</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3358830\" data-linked=\"Coherus down 3% on pricing common stock offering\" data-tweet=\"$CHRS - Coherus down 3% on pricing common stock offering https://seekingalpha.com/news/3358830-coherus-down-3-on-pricing-common-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3358830-coherus-down-3-on-pricing-common-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358829\" data-ts=\"1527074126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIF\" target=\"_blank\">TIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358829-tiffany-higher-on-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tiffany higher on earnings beat</a></h4><ul><li>Tiffany (NYSE:<a href='https://seekingalpha.com/symbol/TIF' title='Tiffany & Co.'>TIF</a>)&nbsp;reports comparable-store sales rose 10% in <a href=\"https://seekingalpha.com/pr/17171635-tiffany-reports-first-quarter-results\" target=\"_blank\">Q1</a>.</li><li>Geographic revenue: Americas: $425M (+9%); Asia-Pacific: $329M (+28%); Japan: $151M (+17%); Europe: $107M (+13%); Other: $22M (-21%).</li><li>Gross margin rate improved 90 bps to 63% reflecting sales leverage on fixed costs and the reduction in wholesale sales of diamonds.</li><li>SG&amp;A expense rate leveraged 230 bps to 43.2%.</li><li>Operating margin rate expanded 320 bps to 19.8%.</li><li>Inventory increased 5.5% Y/Y to $2.32B.</li><li>Store count +4 Y/Y to 314.</li><li><b>FY2018 Guidance</b>:&nbsp;Net sales:&nbsp;increase by a high-single-digit percentage; Comparable sales:&nbsp;mid-to-high-single-digit growth;&nbsp;Operating margin rate: down Y/Y; Interest and other expenses, net: in line Y/Y; Tax rate: in the high 20%;&nbsp;Diluted EPS:&nbsp;$4.50 to $4.70; Free cash flow: at least $400M; Capex: $280M.</li><li>TIF&nbsp;<font color='green'>+10.52%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358815-tiffany-beats-0_31-beats-revenue\" target=\"_blank\">Tiffany beats by $0.31, beats on revenue</a> (May 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358829\" data-linked=\"Tiffany higher on earnings beat\" data-tweet=\"$TIF - Tiffany higher on earnings beat https://seekingalpha.com/news/3358829-tiffany-higher-on-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3358829-tiffany-higher-on-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358827\" data-ts=\"1527074074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARA\" target=\"_blank\">CARA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358827-cara-out-licenses-korsuva-to-vifor-fresenius-for-up-to-520m-shares-up-22-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cara out-licenses Korsuva to Vifor Fresenius for up to $520M; shares up 22% premarket</a></h4><ul><li>Cara Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a>) is up&nbsp;<font color='green'>22%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17171596-cara-therapeutics-vifor-fresenius-medical-care-renal-pharma-vfmcrp-enter-ex-u-s-licensing\" target=\"_blank\">announcement</a> of an agreement with Vifor Fresenius Medical Care Renal Pharma Ltd. for the global rights, except in the U.S., Japan and South Korea, to commercialize KORSUVA (difelikefalin) for the treatment of chronic kidney disease-associated pruritis in dialysis patients.</li><li>Under the terms of the agreement, Cara will receive $50M upfront, up to $30M in regulatory miliestones, up to $440M in commercial milestones and tiered royalties on net sales. Vifor Fresenius will also make a $20M equity investment in Cara at ~$17/share.</li><li>In the U.S., Cara and Fresenius Medical Care North America will promote KORSUVA in Fresenius' dialysis clinics under a profit-sharing arrangement. Cara retains exclusive elsewhere in the U.S.</li><li>Vifor Fresenius Medical Care Renal Pharma Ltd. is a joint company between Vifor Pharma Group and Fresenius Medical Care (NYSE:<a href='https://seekingalpha.com/symbol/FMS' title='Fresenius Medical Care AG & Co. KGAA'>FMS</a>).</li><li>Cara management will host a conference call this morning at 8:30 am ET to discuss the deal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358827\" data-linked=\"Cara out-licenses Korsuva to Vifor Fresenius for up to $520M; shares up 22% premarket\" data-tweet=\"$CARA $CARA $FMS - Cara out-licenses Korsuva to Vifor Fresenius for up to $520M; shares up 22% premarket https://seekingalpha.com/news/3358827-cara-out-licenses-korsuva-to-vifor-fresenius-for-up-to-520m-shares-up-22-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3358827-cara-out-licenses-korsuva-to-vifor-fresenius-for-up-to-520m-shares-up-22-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358826\" data-ts=\"1527074040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETH-USD\" target=\"_blank\">ETH-USD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358826-bitcoin-skids-below-8k\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin skids below $8K</a></h4><ul><li>The big April bounce in cryptocurrencies can probably officially be labeled as \"dead cat\" at this point.</li><li>Bitcoin is<font color='red'> lower by another 1.6%</font>&nbsp;this morning to $7,858 after nearly having touched $10K just two weeks ago.</li><li>Ether (<a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>)&nbsp;<font color='red'>-3.3%</font>&nbsp;to $619, Ripple (<a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>)&nbsp;<font color='red'>-3.5%</font>, Bitcoin Cash (<a href='https://seekingalpha.com/symbol/BCH-USD' title='Bitcoin Cash USD'>BCH-USD</a>)&nbsp;<font color='red'>-8%</font>, Litecoin (<a href='https://seekingalpha.com/symbol/LTC-USD' title='Litecoin USD'>LTC-USD</a>)&nbsp;<font color='red'>-2.8%</font></li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>, <a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>, <a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>, <a href='https://seekingalpha.com/symbol/BCH-USD' title='Bitcoin Cash USD'>BCH-USD</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3358826\" data-linked=\"Bitcoin skids below $8K\" data-tweet=\"$ETH-USD $ETH-USD $XRP-USD - Bitcoin skids below $8K https://seekingalpha.com/news/3358826-bitcoin-skids-below-8k?source=tweet\" data-url=\"https://seekingalpha.com/news/3358826-bitcoin-skids-below-8k\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}